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Article
SARS-CoV-2 structural coverage map reveals viral
protein assembly, mimicry, and hijacking
mechanisms
Sean I O’Donoghue1,2,3,* , Andrea Schafferhans1,4,5 , Neblina Sikta1 , Christian Stolte1 ,
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Abstract
We modeled 3D structures of all SARS-CoV-2 proteins, generating
2,060 models that span 69% of the viral proteome and provide
details not available elsewhere. We found that ~6% of the
proteome mimicked human proteins, while ~7% was implicated in
hijacking mechanisms that reverse post-translational modifi-
cations, block host translation, and disable host defenses; a further
~29% self-assembled into heteromeric states that provided insight
into how the viral replication and translation complex forms. To
make these 3D models more accessible, we devised a structural
coverage map, a novel visualization method to show what is—and
is not—known about the 3D structure of the viral proteome. We
integrated the coverage map into an accompanying online
resource (https://aquaria.ws/covid) that can be used to find and
explore models corresponding to the 79 structural states identified
in this work. The resulting Aquaria-COVID resource helps scientists
use emerging structural data to understand the mechanisms
underlying coronavirus infection and draws attention to the 31%
of the viral proteome that remains structurally unknown or dark.
Keywords bioinformatics; COVID-19; data visualization; SARS-CoV-2; struc-
tural biology
Subject Categories Methods & Resources; Microbiology, Virology & Host
Pathogen Interaction; Structural Biology
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Introduction
Due to the COVID-19 pandemic, many life scientists have recently
switched focus toward SARS-CoV-2 (severe acute respiratory
syndrome coronavirus 2). This includes structural biologists, who
have so far deposited > 1,000 entries in the Protein Data Bank
(PDB; Berman et al, 2000) with details on the molecular conforma-
tion of the 27 viral proteins.
These structures are, in turn, driving molecular modeling studies,
most focused on the spike glycoprotein (e.g., Jaimes et al, 2020;
Gowthaman et al, 2021). Some modeling studies focus on breadth
of coverage, predicting 3D structures for the entire SARS-CoV-2
proteome (Waman et al, 2021); this has been done using AlphaFold
(preprint: Heo & Feig, 2020; Senior et al, 2020), C-I-TASSER (Zheng
et al, 2021), MODELLER (Sedova et al, 2020; Srinivasan et al, 2020;
Alsulami et al, 2021), Rosetta (preprint: Heo & Feig, 2020), and
SWISS-MODEL (Waterhouse et al, 2018). Unfortunately, some of
these methods have been found to give predictions that vary greatly
(preprint: Heo & Feig, 2020), raising accuracy concerns; addition-
ally, these approaches generally focus on deriving only one or a
minimal number of structural states for each viral protein. To date,
there has been no published, systematic analysis examining all
structural states with supporting structural evidence.
Our goal in this work was to address these limitations via a
depth-based strategy that models, for each viral protein, all states
with related 3D structures in the PDB—this includes structures
determined for other coronaviruses, such as SARS-CoV (severe
acute respiratory syndrome coronavirus) or MERS-CoV (Middle East
respiratory syndrome coronavirus), as well as many structures from
more distantly related viruses, such as those causing polio or foot-
and-mouth disease.
1 Garvan Institute of Medical Research, Darlinghurst, NSW, Australia
2 CSIRO Data61, Canberra, ACT, Australia
3 School of Biotechnology and Biomolecular Sciences (UNSW), Kensington, NSW, Australia
4 Department of Bioengineering Sciences, Weihenstephan-Tr. University of Applied Sciences, Freising, Germany
5 Department of Informatics, Bioinformatics & Computational Biology, Technical University of Munich, Munich, Germany
6 School of Life Sciences, The University of Dundee, Dundee, UK
7 Institute of Structural and Molecular Biology, University College London, London, UK
*Corresponding author (lead contact). Tel: +61 2 9295 8329; E-mail: sean@odonoghuelab.org
ª 2021 The Authors. Published under the terms of the CC BY 4.0 license Molecular Systems Biology 17: e10079 | 2021 1 of 24
Combining breadth and depth of coverage requires modeling
methods with low computational cost; here, we use only sequence
profile comparisons (Steinegger et al, 2019) to align SARS-CoV-2
sequences onto experimentally derived 3D structures (O’Donoghue
et al, 2015). This generates what we call minimal models, in which
3D coordinates are not modified, but simply mapped onto SARS-
CoV-2 sequences, with coloring used to indicate model quality
(Heinrich et al, 2015).
Minimal models have substantial benefits: It is easy to under-
stand how they were derived, helping assess the validity of insights
gained. Thus, minimal models are broadly useful, even for
researchers who are not modeling experts. Conversely, models
generated by more sophisticated methods (e.g., Senior et al, 2020)
can be more accurate, but it generally requires more time and exper-
tise to assess their accuracy (e.g., preprint: Heo & Feig, 2020) and
the validity of insights gained, thus limiting their usefulness.
Large numbers of models can be generated by such minimal
strategies, raising a new problem: how to visually organize such
complex datasets to be usable. This problem is one instance of what
we consider to be the critical, central issue impeding not just COVID-
19 research, but many areas of the life sciences (O’Donoghue et al,
2018): To address rapidly increasing data complexity, high-
throughput machine learning studies of the kind presented in this
work are not sufficient—the study outcomes also need to be accom-
panied with visual summarizes that help provide both insight and
data navigation for other scientists (O’Donoghue, 2021). Thus, we
introduce a novel concept: a one-stop visualization strategy that
provides an overview of what is known—and not known—about the
3D structure of the viral proteome. This tailored visualization—
called the SARS-CoV-2 structural coverage map—helps researchers
find structural models related to specific research questions.
Once a structural model of interest is found, it can be used to
explore the spatial arrangement of sequence features—i.e., residue-
based annotations, such as nonsynonymous mutations or post-
translational modifications. Here, we integrated the SARS-CoV-2
structural coverage map and 3D models into Aquaria (O’Donoghue
et al, 2015), a web-based, molecular graphic system designed to
simplify feature mapping and make minimal models broadly accessi-
ble to researchers who are not modeling experts. Previously, Aquaria
could only map features from UniProt (The UniProt Consortium,
2019); for this work, we have added features from several additional
sources, and we also refactored Aquaria to improve performance.
The resulting Aquaria-COVID resource (https://aquaria.ws/covid)
comprises a large set of SARS-CoV-2 structural information not
readily available elsewhere. The resource also identifies structurally
dark regions of the proteome, i.e., regions with no significant
sequence similarity to any protein region observed by experimental
structure determination (Perdig~ao et al, 2015). Clearly identifying
such regions helps direct future research to reveal viral protein func-
tions that are currently unknown.
Below, we describe the resource and how the generated struc-
tural models provide new insights into the function of each viral
protein, as well as general insights into how viral proteins self-
assemble, and how they may mimic host proteins (Elde & Malik,
2009) and hijack host processes (Davey et al, 2011).
During the COVID-19 pandemic, the Aquaria-COVID resource
aims to fulfill a vital role by helping scientists more rapidly explore
and assess evidence for the molecular mechanisms that underlie
coronavirus infection—and more easily keep abreast of emerging
knowledge, as new 3D structures and sequence features become
available.
Results
Our study was based on 14 UniProt (The UniProt Consortium, 2019)
sequences that comprise the SARS-CoV-2 proteome (Reagents and
Tools Table). In PDB (Berman et al, 2000), these sequences were
cross-referenced to 1,180 structures, all of which were determined
for SARS-CoV-2. Using HHblits (Steinegger et al, 2019), we found an
additional 880 related structures in PDB—initially determined for
other organisms, but used here as minimal models for SARS-CoV-2
proteins. This gave a total of 2,060 matching structures (Datasets
EV1–EV7) that collectively spanned 69% of the viral proteome
(Dataset EV8), thus leaving the remaining 31% as structurally
unknown or dark (Perdig~ao et al, 2015). The matching structures
were incorporated into Aquaria (O’Donoghue et al, 2015), where
they can be mapped with a wealth of features from UniProt, CATH
(Dataset EV9; Sillitoe et al, 2021), SNAP2 (Hecht et al, 2015), and
PredictProtein (Datasets EV10–EV12; Yachdav et al, 2014), in addi-
tion to user-defined features. These features include residue-based
prediction scores for conservation, disorder, domains, flexibility,
mutational propensity, subcellular location, and transmembrane
helices (see Materials and Methods). To help other researchers use
these models and features, we have extensively refactored Aquaria
to improve cross-platform performance and created a matrix layout
giving access to models for the 14 viral sequences (https://aquaria.
ws/covid#matrix). We also created a structural coverage map
▸Figure 1. SARS-CoV-2 structural coverage map.Integrated visual summary showing 79 distinct states found in 2,060 structural models derived by systematically comparing the SARS-CoV-2 proteome against all
experimentally determined 3D structures. Viral proteins are shown as arrows scaled by sequence length, ordered by genomic location, and divided into three groups: (i)
polyprotein 1a (top); (ii) polyprotein 1b (middle); and (iii) virion and accessory proteins (bottom). Above polyprotein 1a and 1b, a ruler indicates residue numbering from
polyprotein 1ab; above selected accessory proteins, numbering indicates sequence length. Sequence regions with unknown structure are indicated with dark coloring.
Regions that have matching structures are indicated with green coloring and with representative structures positioned below. Dark colored residues on the structure
indicate amino acid substitutions, while conserved residues are colored to highlight secondary structure. Below the representative structures, graphs indicate three
distinct states revealed in the matching structures: (i) viral protein hijacking of human proteins (gray coloring; Fig 3), (ii) human proteins that the viral protein may
mimic (orange; Fig 2), or (iii) binding to antibodies, HLA, inhibitory peptides, RNA, or to other viral proteins (green; Fig 4). Bindings between viral proteins form two
disjoint teams: (i) NSP7, NSP8, NSP9, NSP12, and NSP13 (parts of the viral replication and translation complex); and (ii) NSP10, NSP14, and NSP16. Nine viral proteins
(called “suspects”) had no structural evidence for interactions with other viral proteins, or for mimicry or hijacking of human proteins; seven of these (NSP2, NSP6, matrix
glycoprotein, ORF6, ORF7b, ORF9c, and ORF10) are structurally dark proteins, i.e., have no significant similarity to any experimentally determined 3D structure.
Representative structures for each state shown are given in Table 1; the complete list of matching structures is provided in Datasets EV1–EV3. Made using Aquaria and
Keynote.
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(Fig 1)—a novel visual layout based on the viral genome organiza-
tion. The coverage map summarizes key results obtained, including
evidence for viral mimicry (Fig 2A and B) or hijacking of host
proteins (Fig 3A–G), as well as viral protein interactions (Fig 4A
and B). For each region with matching structures, an image of a
single representative structure is shown in Fig 1, colored to convey
alignment quality (Heinrich et al, 2015). Details about these struc-
tures are given in Table 1, which includes details on single, repre-
sentative structures for each distinct state shown in the coverage
map graphs (i.e., hijacking, mimicry, or binding). Each of these
structural states can also be accessed via hyperlinks in the online
version of the coverage map at the Aquaria-COVID resource (http://
aquaria.ws/covid). In the following three sections of the Results, we
systematically present key findings from structural models associ-
ated with three regions of the viral genome; these sections are
intended to be read with close reference to Fig 1.
Polyprotein 1a
Polyprotein 1a (a.k.a. PP1a) derives from polyprotein 1ab (a.k.a.
PP1ab) and is cleaved into 10 proteins (NSP1–NSP10) that modify
viral proteins, disable host defenses, and support viral replication.
NSP1 derives from residues 1–180 of PP1a and is thought to inter-
act with the ribosome, suppressing translation of host mRNAs and
promoting their degradation (Kamitani et al, 2009). We found four
structures matching to an N-terminal region (NTR; PP1a 10–127),
two of which were determined for SARS-CoV-2 and two from SARS-
CoV. None of these structures showed either mimicry or interaction
with other proteins or RNA; thus, on the coverage map (Fig 1), these
structures are depicted using only a single representative image
derived from one of the SARS-CoV-2 structures (Aquaria model
https://aquaria.ws/P0DTC1/7k3n). Unusually, these structures
provide few functional insights (Almeida et al, 2007), partly because
they had a unique fold with no matches in CATH (Sillitoe et al,
2021). In contrast, a small C-terminal region (a.k.a. CTR; PP1a 145–
180) had 14 matching structures, all derived from SARS-CoV-2 and
all showing binding to various ribosome complexes, including 40S,
80S, and the 43S preinitiation complex (Fig 3A). These structures
reveal that NSP1 obstructs host mRNA entry into the ribosome,
thereby blocking innate immune responses (Thoms et al, 2020). On
the coverage map, all structures, such as these, that show viral
hijacking of human proteins are indicated via dark gray-colored
graphs with dotted lines (Fig 1). NSP1 also had two short dark
regions (Fig 1); the N-terminal dark region may be accounted for by
high flexibility (average predicted B-value = 60; see Methods).
NSP2 (PP1a 181–818) may disrupt intracellular signaling by
interacting with host proteins (Cornillez-Ty et al, 2009). Unfortu-
nately, no structural information on these interactions is currently
available, as NSP2 was found to be a dark protein, i.e., had no
matching structures. This may be partly explained by the observa-
tion that, of all 15 PP1ab proteins, NSP2 had the highest predicted
flexibility (average B-factor = 66), although it also had no predicted
disorder (Dataset EV10).
NSP3 (PP1a 819–2,763) is a large, multidomain protein thought
to perform many functions, including anchoring the viral replication
complex to double-membrane vesicles derived from the endoplas-
mic reticulum (Lei et al, 2018). NSP3 had 483 matching structures—
more than any other viral protein (Fig 1, Dataset EV7); these
structures clustered in 11 distinct sequence regions, each of which
are described below.
NSP3 region 1 (a.k.a. Ubl1; PP1a 819–929) was the least
conserved NSP3 region (average ConSurf score = 3.7; Dataset
EV11), suggesting it adapts to host-specific defenses. Ubl1 is thought
to bind single-stranded RNA and the viral nucleocapsid protein (Lei
et al, 2018). Unfortunately, these interactions were absent in all four
matching structures found (Dataset EV1), which all adopt a
ubiquitin-like topology (CATH 3.10.20.350; Dataset EV9). Although
it has distinct structural differences, Ubl1 may mimic host ubiquitin
(Lei et al, 2018); however, we found no matches to structures of
human ubiquitin, undermining the mimicry hypothesis.
NSP3 region 2 (PP1a 930–1,022) had no matches in CATH and
no matching structures. This was the NSP3 region with lowest
predicted sensitivity to mutation (median sensitivity 0%; Dataset
EV11), highest predicted flexibility (average B-factor = 66), highest
fraction of disordered residues (47%), and highest fraction of resi-
dues predicted to be solvent-accessible (99%). We speculate that
this region acts as a flexible linker and may contain post-
translational modification sites hijacking host signaling, as are often
found in viral disordered regions (Davey et al, 2011).
NSP3 region 3 (PP1a 1,023–1,197) has a macro domain (CATH
3.40.220.10; Dataset EV9) that may counteract innate immunity via
interfering with ADP-ribose (ADPr) modification (Lei et al, 2018).
This was the second least conserved NSP3 region (ConSurf = 3.9;
Dataset EV11) and had the highest fraction of mutationally sensitive
residues (29%), suggesting it is well adapted to specific hosts. This
region had 399 matching structures (Fig 1, Dataset EV1), of which
42 showed NSP3 aligned onto human proteins with moderately high
significance (E ~ 1017), providing evidence for viral mimicry
(Fig 2A, Dataset EV4). The potentially mimicked human proteins
were as follows: GDAP2, MACROD1, MACROD2, MACROH2A1,
MACROH2A2, PARP9, and PARP14—all of which are associated
with ADPr modifications (Rack et al, 2016).
NSP3 region 4 (PP1a 1,198–1,230) was mostly disordered
(1,210–1,230) and had no matching structures.
NSP3 region 5 (PP1a 1,231–1,353), also known as SUD-N, had
one matching structure that adopted a macro-like topology (CATH
3.40.220.30). SUD-N is reported to bind RNA (Lei et al, 2018);
however, the available structure shows this region from SARS-CoV
hijacking PAIP1 (Fig 2B), a human protein implicated in translation
initiation (Grosset et al, 2000).
NSP3 region 6 (PP1a 1,354–1,493), also known as SUD-M, has
another macro-like domain (CATH 3.40.220.20) that may bind both
RNA and host proteins, and take part in viral replication (Lei et al,
2018). However, these interactions were absent in all of the eight
matching structures found (Dataset EV1). Comparing these with
structures matching NSP3 region 3, we see considerable differences
and no evidence of mimicry of host macro domains (Fig 1).
NSP3 region 7 (PP1a 1,494–1,562), also known as SUD-C, has a
glutaredoxin-like topology (CATH 3.40.30.150) and had three
matching structures, one of which also spanned NSP3 region 8.
Based on analysis of these structures, Lei et al (2018) speculated
that this region may bind metal ions and induce oxidative stress.
NSP3 region 8 (PP1a 1,563–1,881) comprises a papain-like
protease (a.k.a. PL-Pro) thought to cleave NSP1–NSP3 from the
polyprotein and to cleave ubiquitin-like modifications from host
proteins (Fig 3C), thereby undermining interferon-induced antiviral
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Figure 2. Viral mimicry of human proteins.
A Lists domain topology for seven human proteins potentially mimicked by the macro domain of NSP3. The list was ranked by alignment significance (HHblits E-value)
and includes a summary of potentially mimicked functions. Each macro domain is numbered to indicate its CATH functional family. The top-ranked proteins
(MACROD2 and MACROD1) remove ADPr from proteins, reversing the effect of ADPr writers (PARP14 and PARP9), and affecting ADPr readers (GDAP2, MACROH2A1, and
MACROH2A2). For PARP9 and PARP14, the table indicates the best alignment of the NSP3 sequence onto the available structures corresponding to each macro
domain.
B Lists three human helicase proteins potentially mimicked by NSP13. The list was ranked by alignment significance (HHblits E-value) and includes a summary of
potentially mimicked functions. We found stronger evidence for mimicry by NSP13 than by NSP3. For each human protein, the 3D structure is shown with Aquaria’s
default coloring scheme, in this case indicating the region of alignment with NSP13 (Fig 1, Dataset EV4). For UPF1 (https://aquaria.ws/P0DTD1/2wjv), the structure
coloring reveals that UPF2 binds to a region not matched by NSP13, suggesting that NSP13 may not bind UPF2. For IGHMBP2 (https://aquaria.ws/P0DTD1/4b3g), the
structure coloring reveals that RNA binds to the region matched by NSP13, suggesting that NSP13 binds RNA. For AQR (https://aquaria.ws/P0DTD1/6jyt), the structure
coloring reveals that the spliceosome binds to a region not matched by NSP13, suggesting that NSP13 may not bind the spliceosome.
Data information: Made using Aquaria, Photoshop, and Keynote.
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activity (Lei et al, 2018). PL-Pro comprises three domains: one with
ubiquitin-like topology (CATH 3.10.20.540), one with ruvA
helicase-like topology (1.10.8.1190), and one with jelly roll topology
(2.60.120.1680). PL-Pro had 65 matching structures, of which 12
showed binding to human ubiquitin-like proteins (Figs 1 and 3C):
five showed binding to ISG15; two showed binding to UBA52; three














NSP3 (PL-Pro) + ubiquitin-like domainsCNSP3 (SUD-N) + PAIP1BNSP1 (CTR) + 40S ribosomal subunitA
Figure 3. Viral hijacking of human proteins.
Summarizes all structural evidence for viral hijacking; collectively, the regions shown cover 7% of the SARS-CoV-2 proteome. The structures are shown with Aquaria’s
default coloring scheme which, for viral proteins, highlights secondary structure as well as any amino acid substitutions from the SARS-CoV-2 sequence; human proteins
and RNA are rendered as semi-transparent.
A Hijacking of ribosomal complexes is shown in 14 matching structures, most of which were determined using the full-length sequence of NSP1 (180 residues);
however, only a ~36 residue fragment was ordered enough to appear in the structures. The coloring scheme highlights the location of this fragment within the
ribosome (https://aquaria.ws/P0DTC1/6zlw), revealing how NSP1 blocks host mRNA translation (Thoms et al, 2020).
B Hijacking of PAIP1 (a.k.a. “PABP-interacting protein 1”) is shown in only one matching structure that was determined using the SUD-N region of NSP3 from SARS-CoV
(Nikulin et al, 2021). The structure (https://aquaria.ws/P0DTC1/6yxj) shows the strong overall sequence similarity in SARS-CoV-2 and reveals that, of the 15 residues
contacting PAIP1, 13 are identical in SARS-CoV-2.
C Hijacking of ubiquitin-like (Ubl) domains is shown in 10 matching structures, of which only one showed simultaneous binding to two Ubl domains (shown above).
The structure (https://aquaria.ws/P0DTC1/5e6j) was determined using NSP3 from SARS-CoV (Bekes et al, 2016), which had strong overall sequence similarity in SARS-
CoV-2; of the 31 residues contacting UBB or UBC, 27 are identical in SARS-COV-2.
D Hijacking of ACE2 is shown in 46 matching structures; however, only two also show binding to SLC6A19 (Yan et al, 2020). In the structure shown here (https://aquaria.
ws/P0DTC2/6m17), spike glycoprotein does not directly bind to SLC6A19.
E Hijacking of NRP1 (a.k.a. neuropilin-1) is shown in only one matching structure (https://aquaria.ws/P0DTC2/7jjc), which includes only a three-residue region from
spike glycoprotein (Daly et al, 2020).
F Hijacking of MPP5 (a.k.a. PALS1, “protein associated with Lin-7 1”) is shown in only one matching structure (https://aquaria.ws/P0DTC4/7m4r), which includes only a
nine-residue region from envelope protein (Liu & Chai, 2021).
G Hijacking of TOMM70 (a.k.a. “translocase of outer mitochondrial membrane protein 70”) is shown in only one matching structure (https://aquaria.ws/P0DTD2/7kdt),
which includes only a 38-residue region from ORF9b protein (Gordon et al, 2020).
Data information: Made using Aquaria and Keynote.
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showed binding to UBB; and two showed binding to UBC. Of these
12 structures, one showed simultaneous binding to both UBB and
UBC; this structure was determined for NSP3 from SARS-CoV;
however, we expect that SARS-CoV-2 NSP3 is also likely to bind
both UBB and UBC, based on strong sequence similarity (Fig 3C).
We also expect that SARS-CoV-2 NSP3 is likely to bind UBA52,
which has 100 and 99% sequence identity to UBB and UBC, respec-
tively, in the regions shown in Fig 3C. Two additional matching
structures showed the PL-Pro region in complex with inhibitory
peptides.
NSP3 region 9 (PP1a 1,882–1,891) had no matching structures,
but also no predicted disorder.
NSP3 region 10 (PP1a 1,892–2,021) comprises a nucleic-acid
binding domain (a.k.a. NAB) thought to bind single-stranded RNA
and to unwind double-stranded DNA (Lei et al, 2018). NAB had
three matching structures that adopt a variant of the Rossmann fold
unique to coronaviruses (CATH 3.40.50.11020).
NSP3 region 11 (PP1a 2,022–2,763) may anchor NSP3 to double-
membrane vesicles (Lei et al, 2018). This was the most conserved
NSP3 region (ConSurf = 4.9; Dataset EV11), suggesting it is less
adapted to specific hosts. This region had no CATH matches and no
matching structures.
NSP4 (PP1a 2,764–3,263) may act with NSP3 and NSP6 to create
the double-membrane vesicles required for viral replication
(Angelini et al, 2014). NSP4 mostly comprised a dark region (PP1a
2,764–3,167) with no CATH matches, no disorder, and multiple
transmembrane helices. The C-terminal region (PP1a 3,168–3,263)
comprised a domain called NSP4C with a DNA polymerase topology
(CATH 1.10.150.420). This region matched to two structures from
MHV-A59 (mouse hepatitis virus A59) and one from FCoV (feline
coronavirus), all with a two-residue alignment gap at PP1a 3,197–
3,198; these structures were all homodimers, yet NSP4C is thought
to act primarily as a monomer (Xu et al, 2009). A final structure
matched to only the last five residues of NSP4C and showed these
residues in complex with NSP5 (Dataset EV1). The functional
importance of this structure is unclear as it is not yet linked to a
scientific publication—possibly, this structure shows a transient
state associated with NSP4-NSP5 cleavage. Given these current
uncertainties, we have not included this structure in Fig 4 or in the
Discussion section on interaction between viral proteins.
NSP5 (a.k.a. 3CL-Pro; PP1a 3,264–3,569) is thought to cleave the
viral polyprotein at 11 sites, resulting in NSP5–NSP16. NSP5
comprises two domains, one with thrombin-like topology (CATH
2.40.10.10) and another with a topology characteristic of viral
proteases (1.10.1840.10). NSP5 had 450 matching structures,
making it the third best characterized viral protein from a structural
perspective (after spike glycoprotein; Fig 1, Dataset EV7). Many of
these matching structures were determined to investigate methods
for inhibiting the protease activity of NSP5; for example, 42 struc-
tures showed binding to inhibitory peptides.
NSP6 (PP1a 3,570–3,859) is a transmembrane protein thought to
act with NSP3 and NSP4 to create double-membrane vesicles
(Angelini et al, 2014). Like NSP2, NSP6 is a dark protein, with no
matching structures—in addition, of the 15 PP1ab proteins, NSP6 is
the least conserved (ConSurf = 4.4; Dataset EV10). NSP6 also had
no CATH matches and no disordered regions.
NSP7 (PP1a 3,860–3,942) is a component of the viral replication
and translation complex (a.k.a. RTC; te Velthuis et al, 2012); it had
35 matching structures, some showing interactions with other viral
proteins (Figs 1 and 4A). In two structures, NSP7 occurred as a
monomer, while 32 of the remaining structures showed NSP7 bound
to NSP8. Of these 32 structures, 21 also showed binding to NSP12;
of these, 15 structures also showed binding to viral RNA (a.k.a.
vRNA); of these, four structures also showed binding to NSP13; of
these, one structure also showed binding to NSP9. These structures
provide insight into how RTC assembles (Fig 4A) and reveal that
the NSP7 adopts a ruvA helicase-like topology (CATH 1.10.8.370),
which comprises an antiparallel helical bundle with distinct
substates, depending on its interaction partners. A final structure
matched to only a nine-residue region of NSP7 and showed this
region presented as an epitope via a complex with HLA (a.k.a.
human leukocyte antigen).
NSP8 (PP1a 3,943–4,140) is another component of the replication
and translation complex (te Velthuis et al, 2012). It features a highly
conserved (ConSurf = 7.3) “tail” segment (PP1a 3,943–4,041),
predominantly helical with some disordered residues and no CATH
matches, followed by a less conserved (ConSurf = 5.7) “head”
domain (PP1a 4,042–4,140) with alpha-beta plait topology (CATH
3.30.70.3540). NSP8 had 34 matching structures, all showing inter-
actions to other proteins (Figs 1 and 4A). One structure showed
binding to NSP12 only; this structure was determined for SARS-CoV
NSP8; however, we inferred that NSP8 and NSP12 from SARS-CoV-
2 may also interact, based on strong sequence similarity (Table 1 &
Dataset EV6). Of the remaining matching structures, 32 showed
binding to NSP7, with 21 also showing binding to NSP12; of these
21, 15 structures also showed binding to viral RNA; of these, four
structures also showed binding to NSP13; of these, one structure
also showed binding to NSP9. As noted for NSP7, these structures
provide insight into how RTC assembles (Fig 4A). A final structure
matched to only a nine-residue region of NSP8 and showed this
region presented as an epitope via a complex with HLA.
NSP9 (PP1a 4,141–4,253) is believed to be another essential
component of the RTC (Miknis et al, 2009). NSP9 had 16 matching
structures with thrombin-like topology (CATH 2.40.10.250), most
arranged in a homodimer, which is thought to be the functional
state (Miknis et al, 2009). One of these structures showed binding to
other RTC components (NSP7, NSP8, NSP12, NSP13, and viral
RNA).
NSP10 (PP1a 4,254–4,392) is thought to act with NSP14 and
NSP16 to cap and proofread RNA during genome replication (Bou-
vet et al, 2012). NSP10 had no CATH matches, yet had 47 matching
structures, most showing interactions to other viral proteins (Figs 1
and 4B). In three matching structures, NSP10 was monomeric, while
in two structures, NSP10 was a homododecamer that formed a
hollow sphere (Fig 4B). Four matching structures showed binding
to NSP14; these structures were determined for SARS-CoV proteins;
however, we inferred that NSP8 and NSP12 from SARS-CoV-2 may
also interact, based on strong sequence similarities (Table 1 &
Dataset EV6). The remaining 38 structures showed binding to
NSP16. Of these 38 structures, four also had viral RNA directly
bound to NSP16, but not to NSP10.
Polyprotein 1b
Polyprotein 1b (a.k.a. PP1b) is cleaved by NSP5 into five proteins
(NSP12–NSP16) that drive replication of viral RNA. These
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proteins were predicted to have no disordered regions, no trans-
membrane helices, and to be conserved (ConSurf = 5.3–6.6;
Dataset EV10).
NSP12 (PP1ab 4,393–5,324) is an RNA-directed RNA polymerase
(a.k.a. RdRp) and is therefore the core component of the viral repli-
cation and translation complex (Yin et al, 2020). NSP12 was one of
the more conserved PP1ab proteins (ConSurf = 6.5; Dataset EV10)
and had a total of 168 matching structures. Of these, 53 showed
binding to viral RNA in the absence of other viral proteins (Fig 1);
all of these 53 structures were determined for proteins from
distantly related viruses (Table 1 & Dataset EV6); however, we
inferred that SARS-CoV-2 NSP12 alone may also interact with viral
RNA, based on SARS-CoV studies (te Velthuis et al, 2012). Of the
remaining structures, 22 showed binding with NSP8; of these, 21
also showed binding with NSP7; of these, 15 also showed binding
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these, one also showed binding with NSP9. As noted above, these
structures provide insight into the order in which proteins assemble
around NSP12 to form RTC (Fig 4A).
NSP13 (PP1ab 5,325–5,925) is a multi-functional helicase thought
to play central roles in replication by unwinding double-stranded
RNA (Subissi et al, 2014; Jang et al, 2020). The N-terminal half of
NSP13 (PP1ab 5,325–5,577) had no matches in CATH, while the C-
terminal half contained two Rossmann fold domains (CATH
3.40.50.300). NSP13 had 128 matching structures, of which only four
showed binding to other RTC proteins (Fig 1, Dataset EV6). Three of
the remaining structures showed direct binding to viral RNA;
although these structures were determined for three very remote
viruses (Table 1 & Dataset EV6), this interaction is consistent with
in vitro SARS-CoV-2 studies (Jang et al, 2020). One of the remaining
structures showed a nine-residue portion of NSP13 presented as an
epitope by HLA, while 24 structures showed potential mimicry of
three human helicase proteins (Fig 1). In nine of these 24 structures,
the NSP13 Rossmann fold domains aligned onto human UPF1 with
very high significance (E ~ 1053), providing evidence for viral
mimicry. Of these nine structures, one showed UPF1 bound to UPF2;
however, we concluded that there was insufficient evidence for
direct UPF2 hijacking (Fig 2B); nonetheless, NSP13 mimicry may
indirectly affect the UPF1/UPF2 interaction, so this is indicated in
Fig 1 via green coloring. In two of the 24 structures, the NSP13 Ross-
mann fold domains aligned onto human IGHMBP2 with high signifi-
cance (E ~ 1032), providing evidence for viral mimicry. Of these
two, one structure showed IGHMBP2 bound to human RNA, suggest-
ing that mimicry may lead to hijacking of human RNA (Fig 2B); this
was indicated in Fig 1 via dark gray coloring. In 13 of the 24 struc-
tures, the first NSP13 Rossmann fold domain aligned onto human
AQR with high significance (E ~ 1027), providing evidence for viral
mimicry. Of these 13 structures, 12 showed AQR bound to the
spliceosome; however, we concluded that there was insufficient
evidence for direct spliceosome hijacking (Fig 2B); nonetheless,
NSP13 mimicry may indirectly affect the AQR/spliceosome interac-
tion, so this is indicated in Fig 1 via green coloring.
NSP14 (PP1ab 5,926–6,452) is a proofreading exoribonuclease
thought to remove 30-terminal nucleotides from RNA, thereby reduc-
ing mutations during viral genome replication (Minskaia et al,
2006). NSP14 had no matches in CATH, but had four matching
structures, all in complex with NSP10 (Figs 1 and 4B).
NSP15 (PP1ab 6,453–6,798) is an uridylate-specific endoribonu-
clease thought to support viral genome replication (Ricagno et al,
2006). The N-terminal region of NSP15 had two domains—one with
a double-stranded RNA-binding topology (CATH 3.30.160.820) and
one with a Rossmann fold CATH 3.40.50.11580)—while the C-
terminal region (PP1ab 6,642–6,798) had no matches in CATH.
NSP15 had 33 matching structures, none of which showed potential
mimicry or interactions with other proteins; however, one structure
showed binding to viral RNA (Fig 1).
NSP16 (PP1ab 6,799–7,096) may methylate viral mRNA caps
following replication, which is thought to be important for evading
host immune defenses (Bouvet et al, 2010). This was also the most
conserved PP1b protein (ConSurf = 6.6; Dataset EV10). NSP16
comprises a single Rossmann fold domain (CATH 3.40.50.150) that
had a total of 94 matching structures. Of these structures, 38 showed
binding to NSP10, of which four additionally showed binding to
vRNA (Figs 1 and 4B). One additional matching structure showed
NSP16 binding to vRNA in the absence of NSP10—however, this
structure derived from a very remote virus (Dataset EV6) and had
only marginal similarity (E-value = 1016); since this interaction
was also inconsistent with SARS-CoV studies (Bouvet et al, 2010),
we judged it to have insufficient evidence and did not include it in
Figs 1 and 4, or Table 1. Another matching structure showed hijack-
ing of human STAT2 by a distantly related flavivirus protein called
NS5 (Dataset EV5), leading to suppression of host immune
responses (Wang et al, 2020). However, the region of the NS5 struc-
ture in direct contact with STAT2 did not match the NSP16 sequence
(Appendix Fig S1A); thus, we judged there was insufficient evidence
to conclude that STAT2 hijacking occurs in SARS-CoV-2, and we did
not include this potential hijacking on the coverage map (Fig 1,
Table 1). Finally, four of the matching structures showed potential
mimicry of the human RNA methyltransferase proteins CMTR1 and
MRM2, with one of the matching structures also bound to human
RNA (Fig 1). However, the alignments between these human
proteins and NSP16 had only marginal E-values (~1011; Dataset
EV4); thus, while these proteins may share similar overall structure,
it is not clear whether they share similar molecular function.
Virion and accessory proteins
The remaining 3ʹ end of the genome encodes 12 proteins, many
involved in virion assembly. Remarkably, our analysis found no
interactions between these proteins.
Spike glycoprotein (a.k.a. S protein) binds host receptors,
thereby initiating membrane fusion and viral entry (Hoffmann et al,
◀ Figure 4. Viral protein interaction teams.
For each team, an assembly matrix is used to show all observed heteromeric states. For both teams, only a small subset of all combinatorially possible heteromeric
states was observed; by highlighting possible transitions between observed states, the matrices suggest the order in which heteromers may assemble. Collectively, the
regions shown cover 29% of the SARS-CoV-2 proteome.
A In team 1, NSP7 (red), NSP8 (cyan), NSP9 (purple), NSP12 (yellow), and NSP13 (green) assemble into the replication and translation complex (RTC). NSP12 alone (top
row, left) can replicate RNA (top row, right). NSP8 binds NSP12 at two sites: (i) at the NSP12 core (2nd row, left); and (ii) via NSP7-mediated cooperative interactions
with NSP12 (4th row, center), greatly enhancing RNA replication (4th row, right). NSP7 + NSP8 alone form a dimer in most structures (4th row, left), but can also form
a tetramer (e.g., https://aquaria.ws/P0DTD1/7jlt) or hexadecamer (e.g., https://aquaria.ws/P0DTD1/2ahm). Replication is also enhanced by NSP13 (5th row, right) and
NSP9 (bottom row, right).
B In team 2, NSP10 monomers (2nd row) can either self-assemble into a spherical dodecamer (top), dimerize with NSP14 (bottom row), or dimerize with NSP16 (third
row). The NSP10 + NSP16 heterodimer was also seen bound to a three-residue RNA segment (fourth row). Residue coloring is used to show that NSP10, NSP14, and
NSP16 appear to interact competitively, as noted in previous studies. In the structures shown, nine NSP10 residues (shown in red on the monomer) formed common
intermolecular contacts in all three oligomers. Within each oligomer, most NSP10 residues involved in intermolecular contacts were shared (red) with at least one
other oligomer; very few NSP10 residues formed contacts specific to that oligomer (blue).
Data information: For brevity, we omitted NSP9, NSP13, and NSP16 monomers, as well as the interaction between NSP4 and NSP5 (see Table 1). Made using Aquaria and
Keynote.
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Table 1. SARS-CoV-2 minimal models used in Fig 1.
Statea 3D Model Identityb Eb Sourcec
NSP1 (NTR) https://aquaria.ws/P0DTC1/7k3n 100% – SARS-CoV-2 (Semper et al, 2021)
NSP1 (CTR) hijacks 40S, 43S, and 80S https://aquaria.ws/P0DTC1/6zlw 100% – SARS-CoV-2 (Thoms et al, 2020)
NSP3 (Ubl1) https://aquaria.ws/P0DTC1/2gri 77% 10–21 SARS-CoV (Serrano et al, 2007)
NSP3 (macro) https://aquaria.ws/P0DTC1/6woj 100% – SARS-CoV-2 (https://doi.org/10.2210/pdb
6WOJ/pdb)
NSP3 (macro) mimics GDAP2 https://aquaria.ws/P0DTC1/4uml 20% 10–15 Human (https://doi.org/10.2210/pdb4UML/
pdb)
NSP3 (macro) mimics MACROD1 https://aquaria.ws/P0DTC1/2x47 27% 10–
160
Human (Chen et al, 2011)
NSP3 (macro) mimics MACROD2 https://aquaria.ws/P0DTC1/4iqy 28% 10–16 Human (Jankevicius et al, 2013)
NSP3 (macro) mimics MACROH2A1 https://aquaria.ws/P0DTC1/1zr5 19% 10–13 Human (Kustatscher et al, 2005)
NSP3 (macro) mimics MACROH2A2 https://aquaria.ws/P0DTC1/2xd7 18% 10–12 Human (https://doi.org/10.2210/pdb2XD7/
pdb)
NSP3 (macro) mimics PARP9 https://aquaria.ws/P0DTC1/5ail 23% 10–10 Human (https://doi.org/10.2210/pdb5AIL/pdb)
NSP3 (macro) mimics PARP14 https://aquaria.ws/P0DTC1/3q6z 29% 10–12 Human (Forst et al, 2013)
NSP3 (SUD-N) + PAIP1 https://aquaria.ws/P0DTC1/6yxj 69% 10–21 SARS-CoV (https://doi.org/10.2210/pdb6XYJ/
pdb)
NSP3 (SUD-M) https://aquaria.ws/P0DTC1/2jzd 80% 10–23 SARS-CoV (Chatterjee et al, 2009)
NSP3 (SUD-C) https://aquaria.ws/P0DTC1/2kqw 78% 10–34 SARS-CoV (Johnson et al, 2010a)
NSP3 (PL-Pro) https://aquaria.ws/P0DTC1/6wrh 100% – SARS-CoV-2 (https://doi.org/10.2210/pdb
6WRH/pdb)
NSP3 (PL-Pro) hijacks ISG15 https://aquaria.ws/P0DTC1/6xa9 100% – SARS-CoV-2 (Klemm et al, 2020)
NSP3 (PL-Pro) hijacks UBA52 https://aquaria.ws/P0DTC1/4rf0 31% 10–31 MERS-CoV (Bailey-Elkin et al, 2014)
NSP3 (PL-Pro) hijacks UBB https://aquaria.ws/P0DTC1/4wur 30% 10–30 MERS-CoV (Lei & Hilgenfeld, 2016)
NSP3 (PL-Pro) hijacks UBC https://aquaria.ws/P0DTC1/4mm3 83% 10–30 SARS-CoV (Ratia et al, 2014)
NSP3 (PL-Pro) hijacks UBB + UBC https://aquaria.ws/P0DTC1/5e6j 82% 10–30 SARS-CoV (Bekes et al, 2016)
NSP3 (PL-Pro) binds inhibitory peptides https://aquaria.ws/P0DTC1/6wuu 99% – SARS-CoV-2 (Rut et al, 2020)
NSP3 (NAB) https://aquaria.ws/P0DTC1/2k87 82% 10–19 SARS-CoV (Serrano et al, 2009)
NSP4 https://aquaria.ws/P0DTC1/3vcb 59% 10–37 MHV-A59 (Xu et al, 2009)
NSP4 binds NSP5 https://aquaria.ws/P0DTC1/7kvg/C 99% – SARS-CoV-2 (https://doi.org/10.2210/pdb
7KVG/pdb)
NSP5 (3CL-Pro) https://aquaria.ws/P0DTC1/5rfa 100% – SARS-CoV-2 (https://doi.org/10.2210/pdb
5RFA/pdb)
NSP5 binds inhibitory peptides https://aquaria.ws/P0DTC1/7bqy 100% – SARS-CoV-2 (Jin et al, 2020)
NSP7 https://aquaria.ws/P0DTC1/2kys 98% 10–33 SARS-CoV (Johnson et al, 2010b)
NSP7 binds HLA https://aquaria.ws/P0DTC1/7lg3 100% – SARS-CoV-2 (https://doi.org/10.2210/pdb
7LG3/pdb)
NSP7 binds NSP8 https://aquaria.ws/P0DTC1/6m5i/A 100% – SARS-CoV-2 (https://doi.org/10.2210/pdb
6M5I/pdb)
NSP7 binds NSP8 + NSP12 https://aquaria.ws/P0DTC1/6m71/C 100% – SARS-CoV-2 (Gao et al, 2020)
NSP7 binds NSP8 + NSP12 + vRNA https://aquaria.ws/P0DTC1/7aap/C 100% – SARS-CoV-2 (Naydenova et al, 2021)
NSP7 binds NSP8 + NSP12 + vRNA + NSP13 https://aquaria.ws/P0DTC1/6xez/C 95% – SARS-CoV-2 (Chen et al, 2020)
NSP7 binds NSP8 + NSP12 + vRNA + NSP13
+ NSP9
https://aquaria.ws/P0DTC1/7cyq/C 100% – SARS-CoV-2 (Yan et al, 2021a)
NSP8 https://aquaria.ws/P0DTC1/6m5i/B 100% – SARS-CoV-2 (https://doi.org/10.2210/pdb
6M5I/pdb)
NSP8 binds NSP12 https://aquaria.ws/P0DTC1/6nus/B 97% 10–76 SARS-CoV (Kirchdoerfer & Ward, 2019)
NSP8 binds HLA https://aquaria.ws/P0DTC1/7lg2 100% – SARS-CoV-2 (https://doi.org/10.2210/pdb
7LG2/pdb)
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Table 1 (continued)
Statea 3D Model Identityb Eb Sourcec
NSP9 https://aquaria.ws/P0DTC1/6wxd 98% – SARS-CoV-2 (https://doi.org/10.2210/pdb
6WXD/pdb)
NSP10 https://aquaria.ws/P0DTC1/2g9t 96% 10–72 SARS-CoV (Su et al, 2006)
NSP10 binds NSP14 https://aquaria.ws/P0DTC1/5c8u/A 95% 10–68 SARS-CoV (Ma et al, 2015)
NSP10 binds NSP16 https://aquaria.ws/P0DTC1/6w61/B 99% – SARS-CoV-2 (https://doi.org/10.2210/pdb
6W61/pdb)
NSP12 https://aquaria.ws/P0DTD1/6yyt 100% – SARS-CoV-2 (Hillen et al, 2020)
NSP12 binds vRNA https://aquaria.ws/P0DTD1/3koa 15% 10–14 FMDV (Ferrer-Orta et al, 2010)
NSP13 https://aquaria.ws/P0DTD1/6jyt 100% 10–63 SARS-CoV (Jia et al, 2019)
NSP13 mimics AQR https://aquaria.ws/P0DTD1/4pj3 20% 10–27 Human (De et al, 2015)
NSP13 mimics AQR + spliceosome https://aquaria.ws/P0DTD1/6id0 20% 10–27 Human (Zhang et al, 2019)
NSP13 mimics UPF1 https://aquaria.ws/P0DTD1/2wjy 24% 10–53 Human (Clerici et al, 2009)
NSP13 mimics UPF1 + UPF2 https://aquaria.ws/P0DTD1/2wjv 24% 10–53 Human (Clerici et al, 2009)
NSP13 mimics IGHMBP2 https://aquaria.ws/P0DTD1/4b3f 25% 10–32 Human (Lim et al, 2012)
NSP13 mimics IGHMBP2 + hRNA https://aquaria.ws/P0DTD1/4b3g 26% 10–31 Human (Lim et al, 2012)
NSP13 binds vRNA https://aquaria.ws/P0DTD1/4n0o 21% 10–19 Arterivirus (Deng et al, 2014)
NSP13 binds HLA https://aquaria.ws/P0DTD1/7lfz 100% – SARS-CoV-2 (https://doi.org/10.2210/pdb
7LFZ/pdb)
NSP14 https://aquaria.ws/P0DTD1/5nfy 95% 10–
142
SARS-CoV (Ferron et al, 2018)
NSP15 https://aquaria.ws/P0DTD1/6wxc 97% – SARS-CoV-2 (Kim et al, 2021)
NSP15 binds vRNA https://aquaria.ws/P0DTD1/6x1b 97% – SARS-CoV-2 (Kim et al, 2021)
NSP16 https://aquaria.ws/P0DTD1/6w4h 99% – SARS-CoV-2 (Rosas-Lemus et al, 2020)
NSP16 mimics CMTR1 https://aquaria.ws/P0DTD1/4n49 14% 10–11 Human (Smietanski et al, 2014)
NSP16 mimics MRM2 https://aquaria.ws/P0DTD1/2nyu 22% 10–11 Human (https://doi.org/10.2210/pdb2NYU/
pdb)
NSP16 mimics CMTR1 + hRNA https://aquaria.ws/P0DTD1/4n48 14% 10–11 Human (Smietanski et al, 2014
NSP16 binds vRNA + NSP10 https://aquaria.ws/P0DTD1/7jyy/A 100% – SARS-CoV-2 (https://doi.org/10.2210/pdb7JYY/
pdb)
Spike glycoprotein https://aquaria.ws/P0DTC2/6vxx 97% – SARS-CoV-2 (Walls et al, 2020)
Spike glycoprotein hijacks ACE2 https://aquaria.ws/P0DTC2/7ct5 100% – SARS-CoV-2 (Guo et al, 2021)
Spike glycoprotein hijacks ACE2 + SLC6A19 https://aquaria.ws/P0DTC2/6m17 100% – SARS-CoV-2 (Yan et al, 2020)
Spike glycoprotein hijacks NRP1 https://aquaria.ws/P0DTC2/7jjc 100% – SARS-CoV-2 (Daly et al, 2020)
Spike glycoprotein binds antibodies https://aquaria.ws/P0DTC2/6w41 100% – SARS-CoV-2 (Yuan et al, 2020a)
Spike glycoprotein binds inhibitory peptides https://aquaria.ws/P0DTC2/5zvm 88% 10–33 SARS-CoV (Xia et al, 2019)
ORF3a https://aquaria.ws/P0DTC3/6xdc 100% – SARS-CoV-2 (preprint: Kern et al, 2020)
ORF3a binds APOA1 https://aquaria.ws/P0DTC3/7kjr 100% – SARS-CoV-2 (preprint: Kern et al, 2020)
Envelope protein https://aquaria.ws/P0DTC4/5x29 85% 10–35 SARS-CoV (Surya et al, 2018)
Envelope protein hijacks MPP5 https://aquaria.ws/P0DTC4/7m4r 100% – SARS-CoV-2 (https://doi.org/10.2210/pdb
7M4R/pdb)
ORF7a https://aquaria.ws/P0DTC7/6w37 100% – SARS-CoV-2 (https://doi.org/10.2210/pdb
6W37/pdb)
ORF8 https://aquaria.ws/P0DTC8/7jtl 99% – SARS-CoV-2 (Flower et al, 2021)
Nucleocapsid protein (NTD) https://aquaria.ws/P0DTC9/6yi3 96% – SARS-CoV-2 (https://doi.org/10.2210/pdb6YI3/
pdb)
Nucleocapsid protein (NTD) binds antibody https://aquaria.ws/P0DTC9/7cr5 100% – SARS-CoV-2 (Daly et al, 2020)
Nucleocapsid protein (NTD) binds HLA https://aquaria.ws/P0DTC9/7kgr 100% – SARS-CoV-2 (Szeto et al, 2021)
Nucleocapsid protein (NTD) binds vRNA https://aquaria.ws/P0DTC9/7acs 96% – SARS-CoV-2 (Dinesh et al, 2020)
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2020). This protein has five domains: one with jelly roll topology
(CATH 2.60.120.960), two alpha-beta plaits (3.30.70.1840), and two
heptad repeat regions, called HR1 (1.20.5.300) and HR2
(1.20.5.790). Aquaria found a total of 474 matching structures—
making this the second best characterized viral protein from a struc-
tural perspective (Fig 1, Dataset EV7). Of the matching structures,
46 showed hijacking of ACE2 (a receptor for SARS-CoV and SARS-
CoV-2 entry); in two of these structures, ACE2 was also bound to
SLC6A19, which had no direct contact with spike glycoprotein
(Fig 3D). An additional matching structure showed hijacking of
NRP1, another receptor that may facilitate viral entry (Fig 3E). Two
further matching structures showed binding between DPP4 and
spike glycoprotein from MERS-CoV—however, based on analysis of
these structures (Appendix Fig S1B) combined with previous
in vitro studies (Discussion), we considered that the evidence does
not support binding between DPP4 and spike glycoprotein from
SARS-CoV-2. Thus, potential hijacking of DPP4 was not included in
Fig 1, although the matching structure evidence is included in
Dataset EV5. Finally, 224 matching structures showed spike glyco-
protein bound to antibodies, and nine structures showed binding to
inhibitory peptides.
ORF3a may act as a homotetramer, forming an ion channel in
host cell membranes that helps with virion release (Lu et al, 2006).
ORF3a had two matching structures, both showing the protein as a
dimer and thought to represent inactivated states; one structure
additionally showed binding to human APOA1, which was used as
an experimental technique to study ORF3a in lipid nanodiscs
(preprint: Kern et al, 2020). Thus, APOA1 binding does not repre-
sent hijacking, and this interaction is therefore indicated on the
coverage map with green coloring (Fig 1).
The envelope protein (a.k.a. E protein) matched four structures,
of which one was a monomer and two showed a homopentamer,
thought to span the viral envelope and form an ion channel (Surya
et al, 2018). Finally, one structure showed a nine-residue region of
E protein hijacking MPP5 (a.k.a. PALS1), a human protein normally
associated with intercellular junctions (Fig 3F).
The matrix glycoprotein (a.k.a. M protein) is also thought to be
part of the viral envelope (Vennema et al, 1996). The matrix glyco-
protein had no matching structures.
ORF6 may block expression of interferon-stimulated genes (e.g.,
ISG15) that have antiviral activity (Frieman et al, 2007). ORF6 had
no matching structures.
ORF7a may interfere with the host cell surface protein BST2,
preventing it from tethering virions (Taylor et al, 2015). ORF7a had
four matching structures that adopt an immunoglobulin-like topol-
ogy (CATH 2.60.40.1550); this fold is believed to facilitate hijacking
of monocyte interactions, thereby dysregulating immune responses
(Zhou et al, 2021).
ORF7b is an integral membrane protein thought to localize to the
Golgi compartment and the virion envelope (Schaecher et al, 2007).
ORF7b had no matching structures.
ORF8 is thought to inhibit type 1 interferon signaling (Li et al,
2020); it is also very different to proteins from other coronaviruses.
ORF8 had two matching structures, both showing a disulfide-linked
homodimer assembly; these structures had a similar fold to ORF7a,
but had dimerization interfaces not seen in other coronaviral
proteins—these interfaces may allow ORF8 to form large-scale
assemblies that mediate immune suppression and evasion (Flower
et al, 2021).
The nucleocapsid protein (a.k.a. N protein) is thought to package
the viral genome during virion assembly through interaction with
the matrix glycoprotein, and also to become ADP-ribosylated
(Grunewald et al, 2018). Depending on its phosphorylation state,
this protein may also switch function, translocating to the nucleus
and interacting with the host genome (Surjit et al, 2005). This
protein had 56 matching structures clustered in two distinct regions.
The N-terminal region (a.k.a. N-NTR; 28–30, 35–184) had 34 match-
ing structures, of which two were homotetramers, eight were
homodimers, 14 were monomers, two showed binding to viral
RNA, and one showed binding to an antibody. In addition, two
structures matched to nine-residue regions of N protein, showing
these regions presented as epitopes by HLA (Szeto et al, 2021),
while a final structure showed a six-residue region assembled as an
homo-16-mer that is implicated in amyloid formation (preprint:
Tayeb-Fligelman et al, 2021). The C-terminal region (a.k.a. N-CTR;
217–230, 243–365) had 22 matching structures, of which 16 were
homodimers, four showed nine-residue regions of N protein
presented as epitopes by HLA (Szeto et al, 2021), and two showed
six-residue regions assembled as homo-16-mers that are implicated
in amyloid formation (preprint: Tayeb-Fligelman et al, 2021). These
structures suggest the oligomerization and RNA-binding activities of
SARS-CoV-2 N protein may be disrupted by therapeutic strategies
based on small molecule inhibitors developed for HCoV-OC43 (hu-
man coronavirus OC43) and MERS-CoV (Peng et al, 2020).
Table 1 (continued)
Statea 3D Model Identityb Eb Sourcec
Nucleocapsid protein (CTD) https://aquaria.ws/P0DTC9/6yun 98% – SARS-CoV-2 (Zinzula et al, 2021)
Nucleocapsid protein (CTD) binds HLA https://aquaria.ws/P0DTC9/7kgo 100% – SARS-CoV-2 (Szeto et al, 2021)
ORF9b https://aquaria.ws/P0DTD2/6z4u 100% – SARS-CoV-2 (https://doi.org/10.2210/pdb
6Z4U/pdb)
ORF9b hijacks TOMM7 https://aquaria.ws/P0DTD2/7kdt 100% – SARS-CoV-2 (Gordon et al, 2020)
aThis table lists 79 distinct protein structural states found in this work, each with details on one representative minimal model, indicated using an Aquaria
identifier. The indicated models correspond to those used to generate representative images and hyperlinks in the online version of Fig 1.
bIn cases showing potential mimicry, the identity scores and E-values indicate similarity between the SARS-CoV-2 viral protein and a human protein.
cIndicates the organism used to derive the corresponding PDB structure as well as the publication associated with the PDB entry; where no publication is yet
available, the DOI for the dataset is given. Organism names are abbreviated as follows: FMDV (foot-and-mouth disease virus); MERS-CoV (Middle East respiratory
syndrome coronavirus); MHV-A59 (mouse hepatitis virus A59); SARS-CoV (severe acute respiratory syndrome coronavirus); SARS-CoV-2 (severe acute respiratory
syndrome coronavirus 2).
12 of 24 Molecular Systems Biology 17: e10079 | 2021 ª 2021 The Authors
Molecular Systems Biology Sean I O’Donoghue et al
ORF9b is a lipid-binding protein thought to interact with mito-
chondrial proteins, thereby suppressing interferon-driven innate
immune responses (Shi et al, 2014). ORF9b matched four structures,
of which three show a homodimer assembly bound to a lipid analog
(Meier et al, 2006). In the remaining structure, ORF9b adopts a very
different 3D conformation and occurs as part of a heterodimer. This
structure shows hijacking of TOMM70 (Fig 3G), a protein of the
outer mitochondrial membrane that plays an important role in inter-
feron response.
ORF9c (a.k.a. ORF14) is currently uncharacterized experimen-
tally; it is predicted to have a single-pass transmembrane helix.
ORF9c had no matching structures.
ORF10 is a predicted protein that currently has limited evidence
of translation (Gordon et al, 2020), has no reported similarity to
other coronavirus proteins, and has no matching structures.
Discussion
The 2,060 matching structures found in this study capture essen-
tially all SARS-CoV-2 protein states with direct, supporting struc-
tural evidence. We used these states to create a structural
coverage map (Fig 1): a concise yet comprehensive visual
summary of what is known—and not known—about the 3D
structure of the viral proteome. Remarkably, we found so few
states showing viral self-assembly (Fig 4), mimicry (Fig 2), or
hijacking (Fig 3) that—excluding non-human host proteins—all
states could be easily included in the coverage map by adding
several rather simple graphs. This may indicate that host interac-
tions are rarely used in COVID-19 infection, consistent with the
notion that viral activity is largely shielded from the host.
However, other experimental techniques have found many more
interactions between viral proteins (Pan et al, 2008), and with
host proteins (Gordon et al, 2020). Thus, the small number of
interactions found in this work more likely indicates limitations
in currently available structural data. We note that it may be
possible to infer many more states from the available structural
data via a range of focused methods (Smith & Sternberg, 2002;
Franzosa & Xia, 2011; Kajan et al, 2014; Du et al, 2017; Gerva-
soni et al, 2020).
Based on a systematic, semi-automated analysis of the 2,060
matching structures, we could divide the 27 SARS-CoV-2 proteins
into four categories: mimics, hijackers, teams, and suspects (Fig 1,
Dataset EV7)—below, we highlight key insights derived within each
of these categories.
Mimics
In this work, we use the term mimic to describe viral proteins that
are similar to host proteins in structure and function (Elde & Malik,
2009). We found structural evidence of mimicry for ~6% of the viral
proteome (Datasets EV1 and EV2), comprising only three SARS-
CoV-2 proteins: NSP3, NSP13, and NSP16 (Dataset EV4).
NSP3 may mimic host proteins containing macro domains,
thereby hijacking ADP-ribose (ADPr) modifications and suppress-
ing host innate immunity (Lei et al, 2018). We found seven
potentially mimicked proteins (Fig 2A); the top-ranked matches
(MACROD2 and MACROD1) remove ADPr from proteins
(O’Sullivan et al, 2019), thus reversing the effect of ADPr writers
(e.g., PARP9 and PARP14, found in lymphoid tissues), and
affecting ADPr readers (e.g., the core histone proteins
MACROH2A1, and MACROH2A2, found in most cells). Thus, we
speculate that, in infected cells, ADPr erasure by NSP3 may
hijack epigenetic regulation of chromatin state (Sch€afer & Baric,
2017), potentially contributing to variation in COVID-19 patient
outcomes. Furthermore, in infected macrophages, activation by
PARP9 and PARP14 may be hijacked by NSP3’s erasure of ADPr,
potentially contributing to the vascular disorders (Iwata et al,
2016) seen in COVID-19 (Varga et al, 2020).
NSP13 may mimic three human helicases, based on stronger
alignment evidence than for NSP3 mimicry (Fig 2). However, we
found no evidence for mimicry of the ~100 other human helicases
(Umate et al, 2011), suggesting that NSP13 mimicry may hijack
specific functions performed by the three helicases. The strongest
evidence was for mimicry of UPF1 (a.k.a. regulator of nonsense
transcripts 1, or RENT1), which acts in the cytoplasm as part of the
nonsense-mediated mRNA decay pathway, known to counteract
coronavirus infection (Wada et al, 2018); we speculate that UPF1
mimicry may hijack this pathway, thus impeding host defenses.
UPF1 also acts in the nucleus, interacting with telomeres; we specu-
late that UPF1 mimicry may be implicated in the connection seen
between COVID-19 severity, age, and telomere length (Aviv, 2020).
The next strongest evidence was for mimicry of IGHMBP2 (a.k.a.
immunoglobulin µ-binding protein 2, or SMBP2), which acts in the
cytoplasm as well as the nucleus, where it interacts with single-
stranded DNA in the class switching region of the genome (Yu et al,
2011), close to IGMH, the gene coding the constant region of
immunoglobulin heavy chains. We speculate that IGHMBP2
mimicry may be implicated in the dysregulation of immunoglobulin-
class switching observed clinically (Bauer, 2020). If these specula-
tions about IGHMBP2 or UPF1 mimicry are correct, they suggest
that NSP13 may sometimes switch roles, from viral replication to
undermining host immunity via host genome interactions.
Finally, our analysis suggested that NSP16 may mimic the
RNA methyltransferase proteins CMTR1 and MRM2. Since
CMTR1 is implicated in interferon response (Haline-Vaz et al,
2008), this mimicry could be a mechanism used by SARS-CoV-2
to undermine host immunity. However, by the alignment criteria
used in this work (O’Donoghue et al, 2015), we considered the
evidence for NSP16 mimicry to be marginal and much weaker
than the evidence for NSP3 and NSP13 mimicry (Dataset EV4).
Thus, we judged that a more detailed analysis of NSP16
mimicry—as presented in Fig 2 for NSP3 and NSP13—was not
warranted.
Hijackers
In this work, we use the term hijacking to describe when viral
proteins disrupt host processes (Davey et al, 2011). We expect that
SARS-CoV-2 will hijack many human proteins (Gordon et al, 2020);
however, our study found direct structural evidence of hijacking
involved only ~7% of the viral proteome (Fig 3), comprising NSP1,
NSP3, spike glycoprotein, envelope protein, and ORF9b protein
(Dataset EV5).
NSP1 has been reported to hijack the small ribosomal subunit
(40S) by blocking entry and translation of host mRNA (Schubert
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et al, 2020), greatly altering the host cell transcriptome (Yuan
et al, 2020b), and effectively blocking translation of antiviral
defense factors, such as DDX58 (a.k.a. retinoic acid-inducible
gene I) or IFNB1 (Thoms et al, 2020). However, the translation
of viral mRNA is facilitated via interactions between the 50
untranslated region (50 UTR) with the N-terminal region of NSP1
(preprint: Shi et al, 2020). The 14 matching structures showing
these hijacking mechanisms may aid structure-based drug design
of anti-COVID-19 therapeutics targeting NSP1 or the 50 UTR of
viral mRNA.
NSP3 is also implicated in suppressing host RNA translation and
in enhancing viral RNA translation. This is reported to involve
hijacking of 40S by a ternary complex of NSP3 with PAIP1 and
PABP; however, to date, the only available structural evidence (Lei
et al, 2021) shows PAIP1 in complex with the SUD-N region of
SARS-CoV NSP3 (Fig 3B). PAIP1 is known to regulate translation
initiation of mRNAs containing a poly(A) tail (Grosset et al, 2000),
which is believed to be characteristic of coronaviral transcripts (Lai
& Stohlman, 1981).
NSP3 is also believed to cleave ubiquitin-like domains from host
proteins, thereby suppressing innate immune responses and disrupt-
ing proteasome-mediated degradation (Lei et al, 2018). We found
matching structures suggesting that NSP3 may bind to three of the
four human ubiquitin proteins (UBB, UBC, and UBA52). These
structures further suggest that each NSP3 molecule can bind up to
two ubiquitin-like domains (Fig 3C), so may also reverse polyubiq-
uitination. We also found structures showing binding to the
ubiquitin-like domains of ISG15 (a.k.a. interferon-stimulated gene
15), which attach to newly synthesized proteins; ISGylation does
not induce degradation but is thought to disturb virion assembly, so
reversing this modification may be necessary for viral replication
(Lei et al, 2018).
Spike glycoprotein is known to bind receptors on the host cell
membrane, thereby initiating membrane fusion and viral entry
(Hoffmann et al, 2020). Multiple matching structures showed details
on the hijacking of ACE2, a carboxypeptidase that normally cleaves
vasoactive peptides. Two of these structures also show binding to
SLC6A19 (a.k.a. B0AT1; Fig 3D), an amino acid transporter that
interacts with ACE2 (Camargo et al, 2009); these structures reveal
additional molecular mechanisms underlying spike glycoprotein
entry (Yan et al, 2021b). Entry may also be facilitated by hijacking
of another cell surface protein called NRP1 (a.k.a. neuropilin-1; Daly
et al, 2020).
Two additional matching structures showed hijacking of the
membrane receptor DPP4 (a.k.a. “Dipeptidyl peptidase IV” or
CD26) by MERS-CoV spike glycoprotein (Dataset EV5). It has been
speculated that DPP4 may also be used by SARS-CoV-2 to enter host
immune cells (Radzikowska et al, 2020), although this speculation
is not supported by in vitro studies (Tai et al, 2020) or by analysis of
the matching structures (Appendix Fig S1B). We concluded that
current evidence does not support binding between DPP4 and spike
glycoprotein from SARS-CoV-2, so we did not include this interac-
tion in Figs 1 and 3.
The viral envelope protein is believed to hijack MPP5 (a.k.a.
PALS1), preventing it from performing its normal role in intracellu-
lar tight junctions and thereby driving lung epithelium disruption in
coronavirus infection (Teoh et al, 2010). Currently, this hijacking is
captured in only one structure (Table 1) that lacks a supporting
scientific publication and matches only a nine-residue region of E
protein (Fig 3F).
ORF9b protein hijacking of the outer mitochondrial membrane
protein TOMM70 (Fig 3G) is reported to be one of the key viral-
mitochondrial interactions occurring during infection; however,
much about this interaction remains unclear, and currently, it is
captured in only one structure (Gordon et al, 2020).
Teams
We found structural evidence of interaction between viral proteins
for ~29% of the viral proteome (Fig 4), comprising eight SARS-CoV-
2 proteins; these proteins divided into two disjoint teams, described
below.
Team 1 comprised NSP7, NSP8, NSP9, NSP12, and NSP13, all
members of the viral replication and translation complex (Fig 4A).
NSP12 alone can replicate RNA, as can NSP7 + NSP8 acting
together (te Velthuis et al, 2012). However, replication is greatly
stimulated by cooperative interactions between the RTC proteins
(Kirchdoerfer & Ward, 2019). Using an assembly matrix layout
revealed that, of the many possible heteromeric combinations, only
a small number were observed among the >200 structures matching
these proteins (Fig 4A). The matrix also suggests the order in which
RTC components may assemble, and, by omission, makes clear that
several proteins implicated in genome replication (Subissi et al,
2014) are missing (NSP3, NSP10, NSP14, and NSP16). These
outcomes demonstrate the value of systematically modeling all
available structural states, rather than only one or few states per
protein.
Team 2 comprised NSP10, NSP14, and NSP16 (Fig 4B). All
matching structures found for NSP14 and many found for NSP16
showed binding with NSP10, consistent with the belief that
NSP10 is required for NSP16 RNA-cap methyltransferase activity
(Decroly et al, 2011), and also for NSP14 methyltransferase and
exoribonuclease activities (Ma et al, 2015). NSP10 was found to
form a homododecamer, and all three observed oligomeric states
involving NSP10 share a common binding region (Fig 4B),
consistent with previous reports (Bouvet et al, 2014). This,
together with the four heteromeric states observed among the
>100 matching structures involving these proteins, suggested that
NSP10, NSP14, and NSP16 interact competitively—in contrast to
the mostly cooperative interactions seen in team 1. We speculate
that NSP10 may be produced at higher abundance than
NSP14 or NSP16, as it could otherwise be rate limiting for viral
replication.
Finally, it is noteworthy that no interactions were found between
the 12 virion or accessory proteins (Fig 1, bottom third), many of
which are known to assemble to form the mature virus particle.
This, again, highlights limitations in currently available structural
data.
Suspects
This leaves 14 of the 27 viral proteins in a final category we call
suspects (Dataset EV7): These are proteins thought to play key roles
in infection, but having no structural evidence of interaction with
other proteins (viral or human). We divided the suspects into two
groups, based on matching structures.
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Group 1 suspects were those with at least one matching struc-
ture: NSP4, NSP5, NSP15, ORF3a, ORF7a, and ORF8, and nucleo-
capsid protein. Some of these have been well studied (e.g., NSP5
had 450 matching structures). Yet none of these proteins had
significant similarity to any experimentally determined 3D struc-
ture involving human proteins or to any structure showing inter-
actions between viral proteins—based on the methods used in
this work.
Group 2 suspects were those with no matching structures:
NSP2, NSP6, matrix glycoprotein, ORF6, ORF7b, and ORF9c, and
ORF10. These are structurally dark proteins (Perdig~ao et al,
2015), meaning not only is their structure unknown, but also that
they have no significant sequence similarity to any experimentally
determined 3D structure—based on the methods used in this
work. Thus, these are the worst characterized viral proteins from
a structural perspective (Fig 1, Dataset EV7). These proteins are
ripe candidates for advanced modeling strategies, e.g., using
predicted residue contacts combined with deep learning (Senior
et al, 2020).
Structural coverage
In combination, these dark proteins and all dark regions found in
our analysis accounted for 31% of the viral proteome (Dataset EV8);
this was somewhat lower than the 54% average darkness found
across all viral proteomes in SwissProt (Perdig~ao et al, 2015), indi-
cating that coronaviruses are comparatively well studied. Only
3.9% of the dark proteome was predicted to be disordered,
compared with 2.0% for the non-dark proteome (Dataset EV8).
Thus, disorder did not account for the majority (96%) of the dark
proteome, which remains largely unexplained, consistent with
previous observations (Perdig~ao et al, 2015).
Within the non-dark or modellable fraction of the proteome
(69%), a total of 26 CATH superfamilies assignments were found.
We note that exactly the same 26 CATH assignments were also
found in the proteome of SARS-CoV (Dataset EV9). Furthermore,
based on PredictProtein, the SARS-CoV-2 proteome was also found
to have a very similar distribution for predicted secondary structure
content, compared to both SARS-CoV and MERS-CoV (Dataset
EV12).
In both SARS-CoV and SARS-CoV-2 proteomes, the most
common topology was the Rossmann fold, which had five recur-
rences (in NSP3, NSP15, NSP16, and twice in NSP13), followed by
the alpha-beta plait and macro-like topologies—each with three
recurrences. An additional five topologies each had two recurrences
(ruvA helicase-like, thrombin-like, ubiquitin-like, jelly roll, and
heptad repeat). These recurring topologies could be grouped into
three broad functional categories: RNA interaction (especially
unwinding), protein modification (removal of ADPr or of ubiquitin-
like attachments), and protein oligomerization. Of the five remain-
ing, non-recurring topologies, three also shared these functions; this
left a final two topologies, glutaredoxin-like and immunoglobulin-
like, that belonged to two additional functional categories—redox
metabolism and immune dysregulation, respectively (Dataset EV9).
Identifying these five broad functional categories and eight recurring
topologies may help focus future research efforts on understanding
the molecular mechanisms of the viral proteome, and on developing
antiviral drugs.
Finally, we note that the 26 CATH superfamilies covered only
33% of the total proteome, thus leaving 36% of the proteome with
structural information that could not be assigned to existing topolo-
gies based on the current CATH library (version 4.3). These unas-
signed structural regions are ripe candidates for further structural
characterization.
Conclusions
In conclusion, we have assembled a wealth of information, not
available from other resources, about the structure of the viral
proteome. Our analysis of these data has provided insight into
how viral proteins self-assemble, how NSP3 and NSP13 may
mimic human proteins, and how viral hijacking reverses post-
translational modifications, blocks host translation, and disables
host defenses. In addition, our study helps direct future research
by quantifying and drawing attention to aspects of the viral
proteome that remain unknown; this includes regions with
unknown structure, as well as regions with known structure but
unknown function. These outcomes are visually summarized in
the structural coverage map (Fig 1), a novel layout concept that
not only provides an insightful overview of available structural
evidence, but can also be used as a navigation aid, helping
researchers find and explore 3D models of interest. The resulting
Aquaria-COVID resource (https://aquaria.ws/covid) aims to fulfill
a vital role during the ongoing COVID-19 pandemic, helping
scientists use emerging structural data to understand the molecu-
lar mechanisms underlying coronavirus infection.
Materials and Methods
Reagents and Tools table




Polyprotein 1a UniProt P0DTC1
Polyprotein 1ab UniProt P0DTD1
Spike glycoprotein UniProt P0DTC2
ORF3a protein UniProt P0DTC3
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Reagents and Tools table (continued)
Resource Reference or source
Identifier or version
number
Envelope protein UniProt P0DTC4
Matrix glycoprotein UniProt P0DTC5
ORF6 protein UniProt P0DTC6
ORF7a protein UniProt P0DTC7
ORF7b protein UniProt P0DTD8
ORF8 protein UniProt P0DTC8
Nucleocapsid protein UniProt P0DTC9
ORF9b protein UniProt P0DTD2
ORF9c protein UniProt P0DTD3
ORF10 protein UniProt A0A663DJA2
Software
HH-suite https://github.com/soedinglab/hh-suite/releases/tag/v3.3.0 3.3.0 (ac765987bd)
HMMER http://hmmer.org/ 3.3
cath-resolve-hits https://cath-tools.readthedocs.io/en/latest/ v0.16.2-0-ga9f860c














CATH nr40 ftp://orengoftp.biochem.ucl.ac.uk/cath/releases/all-releases/v4_3_0 11 September, 2019
PSSH2 https://doi.org/10.5281/zenodo.4279163 27 June, 2020
Methods and Protocols
SARS-CoV-2 sequences
This study was based on the 14 protein sequences provided in
UniProtKB/SwissProt (downloaded March 11, 2021; https://www.
uniprot.org/statistics/) as comprising the SARS-CoV-2 proteome
(Reagents and Tools table). SwissProt provides polyproteins 1a
and 1ab (a.k.a. PP1a and PP1ab) as two separate entries, both
identical for the first 4,401 residues; PP1a then has four addi-
tional residues (“GFAV”) not in PP1ab, which has 2,695 addi-
tional residues not in PP1a. SwissProt also indicates residue
positions at which the polyproteins become cleaved into protein
fragments, named NSP1 though NSP16. The NSP11 fragment
comprises the last 13 residues of PP1a (4,393–4,405). The first 9
residues of NSP12 are identical to the first nine of NSP11, but
the rest of that 919 residue long protein continues with a dif-
ferent sequence due to a functionally important frameshift
between ORF1a and ORF1b (Nakagawa et al, 2016). Thus,
following cleavage, the proteome comprises a final total of 27
separate proteins.
Sequence-to-structure alignments
The 14 SARS-CoV-2 sequences were then mapped onto all related 3D
structures using the PSSH2 tools, which run the Aquaria sequence-
to-structure processing pipeline (O’Donoghue et al, 2015). As a first
step in this process, each sequence was systematically compared
with sequences derived from all 176,388 available PDB entries
(downloaded March 27, 2021). These comparisons used HHblits
v3.3.0 and UniRef30 (components of HH-suite; Steinegger et al,
2019) in the processing pipeline defined previously (O’Donoghue
et al, 2015), accepting all sequence-to-structure alignments with a
significance threshold E ≤ 1010 or with a pairwise identity ≥ 90%.
The resulting set of sequence-to-structure alignments for SARS-CoV-
2 (Data ref: Schafferhans et al, 2021) was added to PSSH2, a database
with over 100 million sequence-to-structure alignments, covering all
SwissProt sequences (Data ref: Schafferhans & O’Donoghue, 2020).
Each time a user visits an Aquaria web page corresponding to a
viral protein, Aquaria performs the following steps:
1 The UniProt primary accession is used in a database query to
find all exactly matching chains in the latest version of the PDB
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(updated weekly), using the sequence cross-references given in
each PDB entry. Sequence-to-structure alignments are then
created based on the information provided in each PDB entry.
2 In addition, the UniProt primary accession is converted to an
MD5 hash generated from the corresponding protein sequence;
the MD5 hash is then used to return a list of all related PDB
chains and sequence-to-structure alignments stored in PSSH2.
3 The results retrieved from (1) and (2) are processed to merge
any duplicates, by checking whether the alignments from the
PDB record and from PSSH2 overlap, using the criteria previ-
ously described (O’Donoghue et al, 2015).
4 In the case of polyprotein 1a and 1ab, we additionally merged
matches that occurred in the overlapping regions of sequence
(NSP1-NSP10); this ensures that the same number of matching
structures is shown in these regions for both proteins.
5 The final, merged set of sequence-to-structure alignments are
then clustered as described previously (O’Donoghue et al, 2015).
The final counts for matching structures shown on the Aquaria
interface, and used in this work, are based on distinct PDB chain
entries. This means that whenever one viral protein sequence
matched to two duplicate chains occurring the same PDB entry, this
was counted as only one distinct matching structure; however, when-
ever two viral protein sequences matched to two distinct chains in
one PDB entry, this was counted as two distinct matching structures.
For each sequence-to-structure alignment derived from HHblits,
the Aquaria interface shows the pairwise sequence identity score,
thus providing an intuitive indication of how closely related the
given region of SARS-CoV-2 is to the sequence of the matched struc-
ture. However, to more accurately assess the quality of the match,
Aquaria also gives an E-value, calculated by comparing two hidden
Markov models (HMMs), one generated for each of these two
sequences. Note that these E-values depend on current knowledge
and, in some cases, can change dramatically as new sequences or
structures become available.
All SARS-CoV-2 matching structures derived in this work can be
directly accessed from links provided in Datasets EV1–EV3; addition-
ally, the underlying SARS-CoV-2 sequence-to-structure alignments
are available online for download (Data ref: Schafferhans et al, 2021),
as is the full PSSH2 database (Data ref: Schafferhans & O’Donoghue,
2020). In Datasets EV1–EV3, alignments derived entirely from PDB
annotations are indicated via a null E-value (“-”), to distinguish them
from PSSH2-derived alignments. Note that PSSH2 alignments were
generated based on the full-length protein sequence used in the
experiment to derive each PDB entry (“SEQRES”); this sequence often
includes regions that are not visible in the final structure due to lack
of data (typically occurring in regions with intrinsic disorder).
As indicated above, all new PDB structures are automatically
imported into Aquaria each week. Thus, structures determined for
SARS-CoV-2 proteins are available via the Aquaria web interface
within a week after they are released. Updates to the PSSH2 entries
that map from SARS-CoV-2 sequences to structures from related
organisms are planned quarterly, while updates for the complete
PSSH2 database are planned annually.
Alignment E-value threshold
In this work, we have used an HHblits E-value of 1010 as the
primary threshold for predicting structure based on sequences. This
threshold was derived from a detailed assessment of specificity and
sensitivity of structure predictions (O’Donoghue et al, 2015), in
which two structures were assessed to be similar if they had ≥ 30%
structural overlap, as measured by COPS (Frank et al, 2010).
According to this assessment, using E ≤ 1010 should result in a 1%
false positive rate and 83% recovery rate. However, in the 5 years
since this previous assessment was done, HHblits has been substan-
tially updated; thus, for this work we decided to do a preliminary
re-assessment of these benchmarks. Unfortunately, COPS has since
been discontinued; thus, for benchmarking accuracy and precision,
we used CATH instead (Sillitoe et al, 2021). Our test data set
comprised 23,028 sequences from the CATH nr40 data set. We built
individual sequence profiles against UniClust30 and used these pro-
files to search against “PDB_full”, a database of HMMs for all PDB
sequences. We then evaluated how many false positives were
retrieved at an E-value lower than 1010, where a false positive was
defined to be a structure with a different CATH code at the level of
homologous superfamily (H) or topology (T). We compared the
ratio of false positives received with HH-suite3 and UniClust30
(Steinegger et al, 2019) with a similar analysis for data produced in
2017 with HH-suite2 and UniProt20, and found that in both cases
the false positive rate was 2.5% at the homology level (H), and
1.9% at the topology level (T). The recovery rate, i.e., the ratio of
proteins from the CATH nr40 data (with < 40% sequence identity)
found by our method that have the same CATH code, was slightly
higher with HH-suite3 (20.8% vs. 19.4%). Differences in benchmark
values, compared with our 2015 assessment, are expected, due to
many differences between CATH and COPS. Given the rather close
similarity in CATH-based values based on HH-suite2 and HH-suite3,
we concluded that the chosen E-value cutoff is still valid.
PredictProtein features
To facilitate analysis of SARS-CoV-2 sequences, we enhanced the
Aquaria resource to include PredictProtein features (Yachdav et al,
2014), thus providing a very rich set of predicted features for all
Swiss-Prot sequences. The five PredictProtein feature sets used in
this work were fetched via:
https://api.predictprotein.org/v1/results/molart/P0DTC1
Conservation
The first PredictProtein feature set is generated by ConSurf (Celniker
et al, 2013) and gives, for each residue, a score between 1 and 9,
corresponding to very low and very high conservation, respectively.
These scores estimate the evolutionary rate in protein families,
based on evolutionary relatedness between the query protein and its
homologues from UniProt using empirical Bayesian methods (May-
rose et al, 2004).
Disorder
This feature set gives consensus predictions generated by Meta-
Disorder (Schlessinger et al, 2006), which combines outputs of
several structure-based disorder predictors to classify each residue
as either disordered or not disordered.
Flexibility
This feature set predicts, for each residue, normalized B-factor
values expected to be observed in an X-ray-derived structure, gener-
ated by PROFbval (Schlessinger et al, 2006). For each residue,
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PROFbval provides a score between 0 and 100; a score of 50 indi-
cates average flexibility, while ≥ 71 indicates highly flexible resi-
dues.
Solvent accessibility
This feature set gives a two-state prediction for each residue—either
buried or exposed to the solvent—generated by RePROF (Yachdav
et al, 2014).
Topology
This feature set is generated by TMSEG (Bernhofer et al, 2016), a
machine learning model that uses evolutionary-derived information
to predict regions of a protein that traverse membranes, as well as
the subcellular locations of complementary (non-transmembrane)
regions.
For the first four of these feature sets, we also used the Predict-
Protein API to calculate average values for each of the final 27 viral
proteins (Dataset EV10). For NSP1-NSP10, the average values were
generated using the polyprotein 1a sequence; for NSP12-NSP16, the
polyprotein 1ab sequence was used. In addition, we calculated aver-
age values for each of the NSP3 regions (Dataset EV11).
Finally, to facilitate a balanced comparison of the SARS-CoV-2
proteome with that of SARS-CoV and MERS-CoV (Dataset EV12), we
also used the PredictProtein API to fetch secondary structure predic-
tions from RePROF (Yachdav et al, 2014).
SNAP2 features
We further enhanced Aquaria to include SNAP2 (Hecht et al, 2015)
features, which provide information on the mutational propensities





The first SNAP2 feature set provides, for each residue position, a list
of 20 scores that indicate the predicted functional consequences of
the position being occupied by each of the 20 standard amino acids.
Large, positive scores (up to 100) indicate substitutions likely to
have deleterious changes, while negative scores (down to 100)
indicate no likely functional change. From these 20 values, a single
summary score is calculated based on the total fraction of substitu-
tions predicted to have deleterious effect, taken to be those with a
score > 40. The summary scores are used to generate a red to blue
color map, indicating residues with highest to least mutational
sensitivity, respectively.
Mutational score
The second SNAP2 feature set is based on the same 20 scores above,
but calculates the single summary score for each residue as the aver-
age of the individual scores for each of the 20 standard amino acids.
UniProt features
UniProt features are curated annotations, and therefore largely
complement the automatically generated PredictProtein features. In




Unfortunately, the SARS-CoV-2 protein sequences (Reagents and
Tools Table) are not included in the current production release of
CATH (version 4.3; Sillitoe et al, 2021). Thus, for this work, we used
the resources used in the CATH database generation workflow to
create a pre-release version of CATH assignments for these sequences.
For each sequence, CATH superfamily and functional family
(FunFams) assignments were obtained by running HMMER (Mistry
et al, 2013) and cath-resolve-hits (Lewis et al, 2019) against the
CATH-Gene3D v4.3 FunFamsHMM library. Superfamilies are
regions of evolutionarily related protein sequences that are
predicted to have similar 3D structures and to share general biologi-
cal functions. FunFams further partition each superfamily into
subsets expected to have specific biological functions in common
(Sillitoe et al, 2012).
Each CATH superfamily has a unique four-integer identifier, of
which the first three integers identify a collection of superfamilies
that share a common structural topology or fold, but do not have an
evolutionary relation. In this work, we used topologies assigned via
the first three CATH identifiers to assess the recurrence of folds in
the viral proteome.
Dataset EV9 gives a summary of the resulting CATH superfamily
and FunFam assignments for SARS-CoV-2 and related viruses;
further details are available online (Data ref: Bordin, 2021). These
assignments are planned to be integrated in the next release of
CATH (version 4.4), currently scheduled for early 2022.
In addition, we enhanced the Aquaria resource so that, whenever
a user loads a SARS-CoV-2 sequence, the above superfamily and
FunFam assignments are fetched. For all other sequences in Swis-
sProt, these assignments are fetched from the CATH API:
https://github.com/UCLOrengoGroup/cath-api-docs
We further enhanced the Aquaria interface so that, whenever a
user hovers over a representation of a superfamily or FunFam
assigned to a protein sequence, the CATH API is also used to gather
related data. These data are shown in a popup using compact, inter-
active visualizations that give access to detailed information on the
biological function, and phylogenetic distribution of proteins with
the specified superfamily or FunFam.
Aquaria core
For this work, the Aquaria core codebase has been substantially
refactored. We changed all client-server data exchanges to use GET
requests, instead of web sockets as used previously (O’Donoghue
et al, 2015). This allowed us to further implement both server-side
caching and client-side caching, resulting in greatly improved
performance. Another major change was to the user interface,
where we removed the previously used Java applet (O’Donoghue
et al, 2015), and replaced it with Jolecule, a JavaScript-based molec-
ular graphic component (https://jolecule.com/), that we further
augmented to enable feature mapping. In this work, Jolecule was
used to determine the set of residues comprising intermolecular
contacts by selecting all residues for one protein, then applying Jole-
cule’s “Neighbours” function. This highlights all residues in which
any atom is within 5 Å.
Structure coverage matrix
We created a web page featuring a matrix view of the 14 UniProt
sequence and showing the total number of matching structures
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found. This page allows navigation to the corresponding Aquaria
page for each protein sequence (https://aquaria.ws/covid#Matrix).
Structural coverage map
For each contiguous region of the viral proteome with matching
structures, we selected a single representative structure (Fig 1); in
most cases, this was based on identity to the SARS-CoV-2 sequence;
however, in some cases, we chose structures showing the simplest
or most common biological assembly. Under the name of each viral
protein, the total number of matching structures found is indicated
(see Sequence-to-Structure Alignments, above). Below each struc-
ture, a tree graph indicates structural evidence of mimicry (i.e.,
where the viral sequence aligns onto human proteins; Dataset EV4),
hijacking (i.e., where viral proteins directly bind to human proteins;
Dataset EV5), or other types of binding (i.e., where viral proteins
bind antibodies, HLA, RNA, inhibitory peptides, or other viral
proteins; Dataset EV6).
Each state shown in these tree graphs was derived from an auto-
mated analysis that listed all molecules present in each matching
structure. This defined lists of putative states (Datasets EV4–EV6),
which were then manually assessed by visually examining relevant
structures, and by reading source literature. For brevity, we
excluded matching structures showing evidence of mimicry or
hijacking of proteins from other (non-human) host organisms; these
matching structures are, however, included in Datasets EV1–EV3.
Many of the listed putative states were supported by direct evidence
(i.e., at least one structure determined for SARS-CoV-2). For all
putative states with only indirect evidence, each manual assessment
is summarized in the Results, and the final outcomes are indicated
in Datasets EV4–EV6. For a small number of putative states, we
assessed that there was insufficient evidence to conclude that they
occur in SARS-CoV-2; two such cases are highlighted in
Appendix Fig S1.
Figure 1 also indicates dark and non-dark regions of the
proteome, derived by merging all sequence-to-structure align-
ments, and also accounting for structural gaps arising from lack
of data. These regions are specified in Dataset EV8, which also
provides a comparison of disorder in dark versus non-dark
regions, using PredictProtein’s Meta-Disorder service (Schlessinger
et al, 2006).
In addition to summarizing structural evidence, we designed
Fig 1 to help researchers find specific structural states they may be
interested in. Each of the states represented in the coverage map is
hyperlinked to representative matching structures, listed in Table 1.
These links can be accessed via a stand-alone PDF version of Fig 1
hosted online at our associated Aquaria-COVID resource (https://
aquaria.ws/covid).
Assembly matrix
To visually summarize the many structural matches that contain
heteromers, we devised a novel matrix-based layout (Fig 4). Each
structure was first automatically analyzed to determine the iden-
tity and number of macromolecules present. This analysis
resulted in a list of all distinct heteromeric states observed among
the matching structures. For each viral interaction team, we
found key molecules that occurred in most states (NSP12 and
RNA for team 1 and NSP10 for team 2). We used these key mole-
cules to define columns in a matrix that summarizes all observed
states, with each edge between adjacent cells indicating a poten-
tial assembly step. For brevity, we omitted most monomers and
homomers. Each final assembly matrix (Fig 4) shows that only a
small subset of all combinatorial possible states was observed
and provides insight into the order in which heteromers may
assemble.
Data availability
The datasets and computer code produced in this study are available
in the following databases:
• CATH assignments for SARS-CoV-2, SARS-CoV, and MERS-CoV:
Zenodo 4915950 (https://doi.org/10.5281/zenodo.4915950)
• Aquaria code: GitHub (https://github.com/ODonoghueLab/Aqua
ria/releases/tag/v1.0)
• Sequence-to-structure alignments and non-dark regions for SARS-
CoV-2: Zenodo 4934861(https://doi.org/10.5281/zenodo.4934860)
Expanded View for this article is available online.
Acknowledgements
Thanks to Tim Mercer and Giulia Wang (Garvan Institute, Australia), Phil Austin
(University of Sydney, Australia) and Lucy van Dorp (UCL Genetics Institute,
UK) for helpful feedback and discussions, to Ian Sillitoe (UCL, UK) for helpful
advice regarding the CATH API, to Tim Karl, Michael Bernhofer, and Maria Litt-
mann (TUM, Germany) for advice regarding the PredictProtein server. We are
grateful to Max Ott (CSIRO, Australia) for advice on improving the performance
and reliability of the Aquaria web application. SIOD and NS were supported by
the Garvan Research Foundation, Tour de Cure Australia, and Sony Foundation
Australia. JP was supported by the Wellcome Trust (218259/Z/19/Z). NB
acknowledges financial support from the Biotechnology and Biological
Sciences Research Council (BBSRC; https://doi.org/10.13039/501100000268)
project number BB/R009597/1. CD was supported by the Bundesministerium
f€ur Bildung und Forschung (BMBF; https://doi.org/10.13039/501100002347),
project numbers 031L0168 and 01IS17049.
Author contributions
The authors have been listed in order of contribution. SIOD designed this study
and led in coordinating co-author contributions, in data analysis, in manu-
script writing, and in figure preparation. He also participated in the database
generation. AS led in 3D model generation, in PSSH2 validation, and was
involved in data analysis and in writing the manuscript. NS coordinated inte-
gration of Aquaria code improvements and was involved in data analysis, in
writing the manuscript, and in creating the tables. CS led in the design of
graphical user interface elements and contributed to figure generation. SK led
in implementing CATH, SNAP2, and PredictProtein features into Aquaria,
participated in data analysis, and assisted in creating the tables. BKH led the
integration for Jolecule into the Aquaria user interface. SA and MA imple-
mented key new features to the molecular graphics components. JBP contrib-
uted to data analysis and provided strategic input into the manuscript. CD
helped with integration of SNAP2 and PredictProtein features into Aquaria and
was involved in data analysis, in writing the manuscript, and in creating the
tables. NB participated with the implementation of CATH features into Aquaria
and assisted in creating the tables. BR contributed to model generation, over-
saw SNAP2 and PredictProtein developments, and gave strategic input into
the manuscript.
ª 2021 The Authors Molecular Systems Biology 17: e10079 | 2021 19 of 24
Sean I O’Donoghue et al Molecular Systems Biology
Conflict of interest
The authors declare that they have no conflict of interest.
References
Almeida MS, Johnson MA, Herrmann T, Geralt M, W€uthrich K (2007) Novel b-
barrel fold in the nuclear magnetic resonance structure of the replicase
nonstructural protein 1 from the severe acute respiratory syndrome
coronavirus. J Virol 81: 3151 – 3161
Alsulami AF, Thomas SE, Jamasb AR, Beaudoin CA, Moghul I, Bannerman B,
Copoiu L, Vedithi SC, Torres P, Blundell TL (2021) SARS-CoV-2 3D database:
understanding the coronavirus proteome and evaluating possible drug
targets. Brief Bioinform 22: 769 – 780
Angelini MM, Neuman BW, Buchmeier MJ (2014) Untangling membrane
rearrangement in the nidovirales. DNA Cell Biol 33: 122 – 127
Aviv A (2020) Telomeres and COVID-19. FASEB J 34: 7247 – 7252
Bailey-Elkin BA, Knaap RCM, Johnson GG, Dalebout TJ, Ninaber DK, van
Kasteren PB, Bredenbeek PJ, Snijder EJ, Kikkert M, Mark BL (2014) Crystal
structure of the middle east respiratory syndrome coronavirus (MERS-CoV)
papain-like protease bound to ubiquitin facilitates targeted disruption of
deubiquitinating activity to demonstrate its role in innate immune
suppression. J Biol Chem 289: 34667 – 34682
Bauer G (2020) The variability of the serological response to SARS-corona
virus-2: potential resolution of ambiguity through determination of avidity
(functional affinity). J Med Virol 93: 311 – 322
Bekes M, van der Heden van Noort G, Ekkebus R, Ovaa H, Huang T, Lima C
(2016) Recognition of Lys48-linked Di-ubiquitin and deubiquitinating
activities of the SARS coronavirus papain-like protease. Mol Cell 62:
572 – 585
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov
IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28: 235 – 242
Bernhofer M, Kloppmann E, Reeb J, Rost B (2016) TMSEG: novel prediction of
transmembrane helices. Proteins Struct Funct Bioinforma 84: 1706 – 1716
Bordin N (2021) CATH Functional Families assignments for SARS-CoV-2, SARS-
CoV and MERS proteins. zenodo 4915950 (https://doi.org/10.5281/zenodo.
4915950) [DATASET]
Bouvet M, Debarnot C, Imbert I, Selisko B, Snijder EJ, Canard B, Decroly E
(2010) In vitro reconstitution of SARS-coronavirus mRNA cap methylation.
PLoS Pathog 6: e1000863
Bouvet M, Imbert I, Subissi L, Gluais L, Canard B, Decroly E (2012) RNA 30-end
mismatch excision by the severe acute respiratory syndrome coronavirus
nonstructural protein nsp10/nsp14 exoribonuclease complex. Proc Natl
Acad Sci USA 109: 9372 – 9377
Bouvet M, Lugari A, Posthuma CC, Zevenhoven JC, Bernard S, Betzi S, Imbert
I, Canard B, Guillemot J-C, Lecine P et al (2014) Coronavirus Nsp10, a
critical co-factor for activation of multiple replicative enzymes. J Biol Chem
289: 25783 – 25796
Camargo SMR, Singer D, Makrides V, Huggel K, Pos KM, Wagner CA, Kuba K,
Danilczyk U, Skovby F, Kleta R et al (2009) Tissue-specific amino acid
transporter partners ACE2 and collectrin differentially interact with
hartnup mutations. Gastroenterology 136: 872 – 882.e3
Celniker G, Nimrod G, Ashkenazy H, Glaser F, Martz E, Mayrose I, Pupko T,
Ben-Tal N (2013) ConSurf: using evolutionary data to raise testable
hypotheses about protein function. Isr J Chem 53: 199 – 206
Chatterjee A, Johnson MA, Serrano P, Pedrini B, Joseph JS, Neuman BW,
Saikatendu K, Buchmeier MJ, Kuhn P, W€uthrich K (2009) Nuclear magnetic
resonance structure shows that the severe acute respiratory syndrome
coronavirus-unique domain contains a macrodomain fold. J Virol 83:
1823 – 1836
Chen D, Vollmar M, Rossi MN, Phillips C, Kraehenbuehl R, Slade D, Mehrotra
PV, von Delft F, Crosthwaite SK, Gileadi O et al (2011) Identification of
macrodomain proteins as novel O -Acetyl-ADP-ribose deacetylases. J Biol
Chem 286: 13261 – 13271
Chen J, Malone B, Llewellyn E, Grasso M, Shelton PMM, Olinares PDB,
Maruthi K, Eng ET, Vatandaslar H, Chait BT et al (2020) Structural basis
for helicase-polymerase coupling in the SARS-CoV-2 replication-
transcription complex. Cell 182: 1560 – 1573.e13
Clerici M, Mour~ao A, Gutsche I, Gehring NH, Hentze MW, Kulozik A, Kadlec J,
Sattler M, Cusack S (2009) Unusual bipartite mode of interaction between
the nonsense-mediated decay factors, UPF1 and UPF2. EMBO J 28:
2293 – 2306
Cornillez-Ty CT, Liao L, Yates JR, Kuhn P, Buchmeier MJ (2009) Severe acute
respiratory syndrome coronavirus nonstructural protein 2 interacts with a
host protein complex involved in mitochondrial biogenesis and
intracellular signaling. J Virol 83: 10314 – 10318
Daly JL, Simonetti B, Klein K, Chen K-E, Williamson MK, Anton-Plagaro C,
Shoemark DK, Simon-Gracia L, Bauer M, Hollandi R et al (2020)
Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370:
861 – 865
Davey NE, Trave G, Gibson TJ (2011) How viruses hijack cell regulation.
Trends Biochem Sci 36: 159 – 169
De I, Bessonov S, Hofele R, dos Santos K, Will CL, Urlaub H, L€uhrmann R,
Pena V (2015) The RNA helicase Aquarius exhibits structural adaptations
mediating its recruitment to spliceosomes. Nat Struct Mol Biol 22:
138 – 144
Decroly E, Debarnot C, Ferron F, Bouvet M, Coutard B, Imbert I, Gluais L,
Papageorgiou N, Sharff A, Bricogne G et al (2011) Crystal structure and
functional analysis of the SARS-coronavirus RNA Cap 20-O-
methyltransferase nsp10/nsp16 complex. PLoS Pathog 7: e1002059
Deng Z, Lehmann KC, Li X, Feng C, Wang G, Zhang Qi, Qi X, Yu L, Zhang X,
Feng W et al (2014) Structural basis for the regulatory function of a
complex zinc-binding domain in a replicative arterivirus helicase
resembling a nonsense-mediated mRNA decay helicase. Nucleic Acids Res
42: 3464 – 3477
Dinesh DC, Chalupska D, Silhan J, Koutna E, Nencka R, Veverka V, Boura E
(2020) Structural basis of RNA recognition by the SARS-CoV-2
nucleocapsid phosphoprotein. PLOS Pathog 16: e1009100
Du X, Sun S, Hu C, Yao Y, Yan Y, Zhang Y (2017) DeepPPI: boosting prediction
of protein-protein interactions with deep neural networks. J Chem Inf
Model 57: 1499 – 1510
Elde NC, Malik HS (2009) The evolutionary conundrum of pathogen mimicry.
Nat Rev Microbiol 7: 787 – 797
Ferrer-Orta C, Sierra M, Agudo R, de la Higuera I, Arias A, Perez-Luque R,
Escarmıs C, Domingo E, Verdaguer N (2010) Structure of foot-and-mouth
disease virus mutant polymerases with reduced sensitivity to ribavirin. J
Virol 84: 6188 – 6199
Ferron F, Subissi L, Silveira De Morais AT, Le NTT, Sevajol M, Gluais L, Decroly
E, Vonrhein C, Bricogne G, Canard B et al (2018) Structural and molecular
basis of mismatch correction and ribavirin excision from coronavirus RNA.
Proc Natl Acad Sci USA 115: E162 – E171
Flower TG, Buffalo CZ, Hooy RM, Allaire M, Ren X, Hurley JH (2021) Structure
of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein. Proc Natl
Acad Sci USA 118: e2021785118
Forst A, Karlberg T, Herzog N, Thorsell A-G, Gross A, Feijs K, Verheugd P,
Kursula P, Nijmeijer B, Kremmer E et al (2013) Recognition of mono-ADP-
20 of 24 Molecular Systems Biology 17: e10079 | 2021 ª 2021 The Authors
Molecular Systems Biology Sean I O’Donoghue et al
ribosylated ARTD10 substrates by ARTD8 macrodomains. Structure 21:
462 – 475
Frank K, Gruber M, Sippl MJ (2010) COPS benchmark: interactive analysis of
database search methods. Bioinformatics 26: 574 – 575
Franzosa EA, Xia Y (2011) Structural principles within the human-virus
protein-protein interaction network. Proc Natl Acad Sci USA 108:
10538 – 10543
Frieman M, Yount B, Heise M, Kopecky-Bromberg SA, Palese P, Baric RS
(2007) Severe acute respiratory syndrome coronavirus ORF6 antagonizes
STAT1 function by sequestering nuclear import factors on the rough
endoplasmic reticulum/golgi membrane. J Virol 81: 9812 – 9824
Gao Y, Yan L, Huang Y, Liu F, Zhao Y, Cao L, Wang T, Sun Q, Ming Z, Zhang L
et al (2020) Structure of the RNA-dependent RNA polymerase from COVID-
19 virus. Science 368: 779 – 782
Gervasoni S, Vistoli G, Talarico C, Manelfi C, Beccari AR, Studer G, Tauriello G,
Waterhouse AM, Schwede T, Pedretti A (2020) A comprehensive mapping
of the druggable cavities within the SARS-CoV-2 therapeutically relevant
proteins by combining pocket and docking searches as implemented in
pockets 2.0. Int J Mol Sci 21: 5152
Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O’Meara MJ,
Rezelj VV, Guo JZ, Swaney DL et al (2020) A SARS-CoV-2 protein
interaction map reveals targets for drug repurposing. Nature 583:
459 – 468
Gowthaman R, Guest JD, Yin R, Adolf-Bryfogle J, Schief WR, Pierce BG (2021)
CoV3D: a database of high resolution coronavirus protein structures.
Nucleic Acids Res 49: D282 –D287
Grosset C, Chen CY, Xu N, Sonenberg N, Jacquemin-Sablon H, Shyu AB (2000)
A mechanism for translationally coupled mRNA turnover: interaction
between the poly(A) tail and a c-fos RNA coding determinant via a
protein complex. Cell 103: 29 – 40
Grunewald ME, Fehr AR, Athmer J, Perlman S (2018) The coronavirus
nucleocapsid protein is ADP-ribosylated. Virology 517: 62 – 68
Guo L, Bi W, Wang X, Xu W, Yan R, Zhang Y, Zhao K, Li Y, Zhang M, Cai X
et al (2021) Engineered trimeric ACE2 binds viral spike protein and locks it
in “Three-up” conformation to potently inhibit SARS-CoV-2 infection. Cell
Res 31: 98 – 100
Haline-Vaz T, Silva TCL, Zanchin NIT (2008) The human interferon-regulated
ISG95 protein interacts with RNA polymerase II and shows
methyltransferase activity. Biochem Biophys Res Commun 372: 719 – 724
Hecht M, Bromberg Y, Rost B (2015) Better prediction of functional effects for
sequence variants. BMC Genom 16: S1
Heinrich J, Kaur S, O’Donoghue S (2015) Evaluating the effectiveness of color
to convey alignment quality in macromolecular structures. In Hobart,
Australia: IEEE
Heo L, Feig M (2020) Modeling of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) proteins by machine learning and physics-
based refinement. bioRxiv 2020.03.25.008904 [PREPRINT]
Hillen HS, Kokic G, Farnung L, Dienemann C, Tegunov D, Cramer P (2020)
Structure of replicating SARS-CoV-2 polymerase. Nature 584: 154 – 156
Hoffmann M, Kleine-Weber H, Schroeder S, Kr€uger N, Herrler T, Erichsen S,
Schiergens TS, Herrler G, Wu N-H, Nitsche A et al (2020) SARS-CoV-2 cell
entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically
proven protease inhibitor. Cell 181: 271 – 280.e8
Iwata H, Goettsch C, Sharma A, Ricchiuto P, Goh WWB, Halu A, Yamada I,
Yoshida H, Hara T, Wei M et al (2016) PARP9 and PARP14 cross-regulate
macrophage activation via STAT1 ADP-ribosylation. Nat Commun 7: 12849
Jaimes JA, Andre NM, Chappie JS, Millet JK, Whittaker GR (2020) Phylogenetic
analysis and structural modeling of SARS-CoV-2 spike protein reveals an
evolutionary distinct and proteolytically sensitive activation loop. J Mol
Biol 432: 3309 – 3325
Jang K-J, Jeong S, Kang DY, Sp N, Yang YM, Kim D-E (2020) A high ATP
concentration enhances the cooperative translocation of the SARS
coronavirus helicase nsP13 in the unwinding of duplex RNA. Sci Rep 10:
4481
Jankevicius G, Hassler M, Golia B, Rybin V, Zacharias M, Timinszky G,
Ladurner AG (2013) A family of macrodomain proteins reverses cellular
mono-ADP-ribosylation. Nat Struct Mol Biol 20: 508 – 514
Jia Z, Yan L, Ren Z, Wu L, Wang J, Guo J, Zheng L, Ming Z, Zhang L, Lou Z
et al (2019) Delicate structural coordination of the severe acute
respiratory syndrome coronavirus Nsp13 upon ATP hydrolysis. Nucleic
Acids Res 47: 6538 – 6550
Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, Zhang L, Peng C et al
(2020) Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.
Nature 582: 289 – 293
Johnson MA, Chatterjee A, Neuman BW, W€uthrich K (2010a) SARS coronavirus
unique domain: three-domain molecular architecture in solution and RNA
binding. J Mol Biol 400: 724 – 742
Johnson MA, Jaudzems K, W€uthrich K (2010b) NMR structure of the SARS-
CoV nonstructural protein 7 in solution at pH 6.5. J Mol Biol 402:
619 – 628
Kajan L, Hopf TA, Kalas M, Marks DS, Rost B (2014) FreeContact: fast and free
software for protein contact prediction from residue co-evolution. BMC
Bioinformatics 15: 85
Kamitani W, Huang C, Narayanan K, Lokugamage KG, Makino S (2009) A two-
pronged strategy to suppress host protein synthesis by SARS coronavirus
Nsp1 protein. Nat Struct Mol Biol 16: 1134 – 1140
Kern DM, Sorum B, Hoel CM, Sridharan S, Remis JP, Toso DB, Brohawn SG
(2020) Cryo-EM structure of the SARS-CoV-2 3a ion channel in lipid
nanodiscs. BioRxiv Prepr Serv Biol [PREPRINT]
Kim Y, Wower J, Maltseva N, Chang C, Jedrzejczak R, Wilamowski M, Kang S,
Nicolaescu V, Randall G, Michalska K et al (2021) Tipiracil binds to uridine
site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2.
Commun Biol 4: 193
Kirchdoerfer RN, Ward AB (2019) Structure of the SARS-CoV nsp12
polymerase bound to nsp7 and nsp8 co-factors. Nat Commun 10: 2342
Klemm T, Ebert G, Calleja DJ, Allison CC, Richardson LW, Bernardini JP, Lu BG,
Kuchel NW, Grohmann C, Shibata Y et al (2020) Mechanism and
inhibition of the papain-like protease, PLpro, of SARS-CoV-2. EMBO J 39:
e106275
Kustatscher G, Hothorn M, Pugieux C, Scheffzek K, Ladurner AG (2005)
Splicing regulates NAD metabolite binding to histone macroH2A. Nat
Struct Mol Biol 12: 624 – 625
Lai MM, Stohlman SA (1981) Comparative analysis of RNA genomes of mouse
hepatitis viruses. J Virol 38: 661 – 670
Lei J, Hilgenfeld R (2016) Structural and mutational analysis of the
interaction between the Middle-East respiratory syndrome coronavirus
(MERS-CoV) papain-like protease and human ubiquitin. Virol Sin 31:
288 – 299
Lei J, Kusov Y, Hilgenfeld R (2018) Nsp3 of coronaviruses: structures and
functions of a large multi-domain protein. Antiviral Res 149: 58 – 74
Lei J, Ma-Lauer Y, Han Y, Thoms M, Buschauer R, Jores J, Thiel V, Beckmann R,
Deng W, Leonhardt H et al (2021) The SARS-unique domain (SUD) of
SARS-CoV and SARS-CoV-2 interacts with human Paip1 to enhance viral
RNA translation. EMBO J 40: e102277
Lewis TE, Sillitoe I, Lees JG (2019) cath-resolve-hits: a new tool that resolves
domain matches suspiciously quickly. Bioinformatics 35: 1766 – 1767
ª 2021 The Authors Molecular Systems Biology 17: e10079 | 2021 21 of 24
Sean I O’Donoghue et al Molecular Systems Biology
Li J-Y, Liao C-H, Wang Q, Tan Y-J, Luo R, Qiu Y, Ge X-Y (2020) The ORF6, ORF8
and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon
signaling pathway. Virus Res 286: 198074
Lim SC, Bowler MW, Lai TF, Song H (2012) The Ighmbp2 helicase structure
reveals the molecular basis for disease-causing mutations in DMSA1.
Nucleic Acids Res 40: 11009 – 11022
Liu Q, Chai J (2021) Structural basis for SARS-CoV-2 envelope protein in
recognition of human cell junction protein PALS1. Unpubl Raw Dataset
Lu W, Zheng B-J, Xu K, Schwarz W, Du L, Wong CKL, Chen J, Duan S, Deubel
V, Sun B (2006) Severe acute respiratory syndrome-associated coronavirus
3a protein forms an ion channel and modulates virus release. Proc Natl
Acad Sci USA 103: 12540 – 12545
Ma Y, Wu L, Shaw N, Gao Y, Wang J, Sun Y, Lou Z, Yan L, Zhang R, Rao Z
(2015) Structural basis and functional analysis of the SARS coronavirus
nsp14–nsp10 complex. Proc Natl Acad Sci USA 112: 9436 – 9441
Mayrose I, Graur D, Ben-Tal N, Pupko T (2004) Comparison of site-specific
rate-inference methods for protein sequences: empirical bayesian methods
are superior. Mol Biol Evol 21: 1781 – 1791
Meier C, Aricescu AR, Assenberg R, Aplin RT, Gilbert RJC, Grimes JM, Stuart DI
(2006) The crystal structure of ORF-9b, a lipid binding protein from the
SARS coronavirus. Structure 14: 1157 – 1165
Miknis ZJ, Donaldson EF, Umland TC, Rimmer RA, Baric RS, Schultz LW (2009)
Severe acute respiratory syndrome coronavirus nsp9 dimerization is
essential for efficient viral growth. J Virol 83: 3007 – 3018
Minskaia E, Hertzig T, Gorbalenya AE, Campanacci V, Cambillau C, Canard B,
Ziebuhr J (2006) Discovery of an RNA virus 3’->5’ exoribonuclease that is
critically involved in coronavirus RNA synthesis. Proc Natl Acad Sci USA
103: 5108 – 5113
Mistry J, Finn RD, Eddy SR, Bateman A, Punta M (2013) Challenges in
homology search: HMMER3 and convergent evolution of coiled-coil
regions. Nucleic Acids Res 41: e121
Nakagawa K, Lokugamage KG, Makino S (2016) Viral and cellular mRNA
translation in coronavirus-infected cells. Adv Virus Res 96: 165 – 192
Naydenova K, Muir KW, Wu L-F, Zhang Z, Coscia F, Peet MJ, Castro-
Hartmann P, Qian P, Sader K, Dent K et al (2021) Structure of the SARS-
CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP.
Proc Natl Acad Sci USA 118: e2021946118
Nikulin AD, Alipov AA, Lekontseva NV (2021) Hfq from E. coli with inserted
long loop L4 sequence. Unpubl Raw Dataset
O’Donoghue SI (2021) Grand challenges in bioinformatics data visualization.
Front Bioinforma 1: 669186
O’Sullivan J, Tedim Ferreira M, Gagne J-P, Sharma AK, Hendzel MJ, Masson J-
Y, Poirier GG (2019) Emerging roles of eraser enzymes in the dynamic
control of protein ADP-ribosylation. Nat Commun 10: 1182
O’Donoghue SI, Baldi BF, Clark SJ, Darling AE, Hogan JM, Kaur S, Maier-Hein L,
McCarthy DJ, Moore WJ, Stenau E et al (2018) Visualization of biomedical
data. Annu Rev Biomed Data Sci 1: 275 – 304
O’Donoghue SI, Sabir KS, Kalemanov M, Stolte C, Wellmann B, Ho V, Roos
M, Perdig~ao N, Buske FA, Heinrich J et al (2015) Aquaria:
simplifying discovery and insight from protein structures. Nat Methods
12: 98 – 99
Pan J, Peng X, Gao Y, Li Z, Lu X, Chen Y, Ishaq M, Liu D, DeDiego ML,
Enjuanes L et al (2008) Genome-wide analysis of protein-protein
interactions and involvement of viral proteins in SARS-CoV replication.
PLoS One 3: e3299
Peng Y, Du N, Lei Y, Dorje S, Qi J, Luo T, Gao GF, Song H (2020) Structures of
the SARS-CoV-2 nucleocapsid and their perspectives for drug design.
EMBO J 39: e105938
Perdig~ao N, Heinrich J, Stolte C, Sabir KS, Buckley MJ, Tabor B, Signal B, Gloss
BS, Hammang CJ, Rost B et al (2015) Unexpected features of the dark
proteome. Proc Natl Acad Sci USA 112: 15898 – 15903
Rack JGM, Perina D, Ahel I (2016) Macrodomains: structure, function,
evolution, and catalytic activities. Annu Rev Biochem 85: 431 – 454
Radzikowska U, Ding M, Tan Ge, Zhakparov D, Peng Y, Wawrzyniak P, Wang
M, Li S, Morita H, Altunbulakli C et al (2020) Distribution of ACE2, CD147,
CD26, and other SARS-CoV-2 associated molecules in tissues and immune
cells in health and in asthma, COPD, obesity, hypertension, and COVID-19
risk factors. Allergy 75: 2829 – 2845
Ratia K, Kilianski A, Baez-Santos YM, Baker SC, Mesecar A (2014) Structural
basis for the ubiquitin-linkage specificity and deisgylating activity of
SARS-CoV papain-like protease. PLoS Pathog 10: e1004113
Ricagno S, Egloff M-P, Ulferts R, Coutard B, Nurizzo D, Campanacci V,
Cambillau C, Ziebuhr J, Canard B (2006) Crystal structure and
mechanistic determinants of SARS coronavirus nonstructural protein 15
define an endoribonuclease family. Proc Natl Acad Sci USA 103:
11892 – 11897
Rosas-Lemus M, Minasov G, Shuvalova L, Inniss NL, Kiryukhina O, Brunzelle J,
Satchell KJF (2020) High-resolution structures of the SARS-CoV-2 20- O -
methyltransferase reveal strategies for structure-based inhibitor design.
Sci Signal 13: eabe1202
Rut W, Lv Z, Zmudzinski M, Patchett S, Nayak D, Snipas SJ, El Oualid F,
Huang TT, Bekes M, Drag M et al (2020) Activity profiling and crystal
structures of inhibitor-bound SARS-CoV-2 papain-like protease: a
framework for anti–COVID-19 drug design. Sci Adv 6: eabd4596
Schaecher SR, Mackenzie JM, Pekosz A (2007) The ORF7b protein of severe
acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-
infected cells and incorporated into SARS-CoV particles. J Virol 81:
718 – 731
Sch€afer A, Baric R (2017) Epigenetic landscape during coronavirus infection.
Pathogens 6: 8
Schafferhans A, O’Donoghue S (2020) PSSH2 - database of protein sequence-
to-structure homologies. zenodo 4279164 (https://doi.org/10.5281/zenodo.
4279164) [DATASET]
Schafferhans A, O’Donoghue S, Sikta N, Kaur S (2021) Sars-CoV-2 structures --
sequence-to-alignments derived from PDB and from PSSH2, plus dark
regions. zenodo 4934861 (https://doi.org/10.5281/zenodo.4934861)
[DATASET]
Schlessinger A, Yachdav G, Rost B (2006) PROFbval: predict flexible and rigid
residues in proteins. Bioinformatics 22: 891 – 893
Schubert K, Karousis ED, Jomaa A, Scaiola A, Echeverria B, Gurzeler L-A,
Leibundgut M, Thiel V, M€uhlemann O, Ban N (2020) SARS-CoV-2 Nsp1
binds the ribosomal mRNA channel to inhibit translation. Nat Struct Mol
Biol 27: 959 – 966
Sedova M, Jaroszewski L, Alisoltani A, Godzik A (2020) Coronavirus 3D: 3D
structural visualization of COVID-19 genomic divergence. Bioinformatics
36: 4360 – 4362
Semper C, Watanabe N, Savchenko A (2021) Structural characterization of
nonstructural protein 1 from SARS-CoV-2. iScience 24: 101903
Senior AW, Evans R, Jumper J, Kirkpatrick J, Sifre L, Green T, Qin C, Zıdek A,
Nelson AWR, Bridgland A et al (2020) Improved protein structure
prediction using potentials from deep learning. Nature 577: 706 – 710
Serrano P, Johnson MA, Almeida MS, Horst R, Herrmann T, Joseph JS, Neuman
BW, Subramanian V, Saikatendu KS, Buchmeier MJ et al (2007) Nuclear
magnetic resonance structure of the N-terminal domain of nonstructural
protein 3 from the severe acute respiratory syndrome coronavirus. J Virol
81: 12049 – 12060
22 of 24 Molecular Systems Biology 17: e10079 | 2021 ª 2021 The Authors
Molecular Systems Biology Sean I O’Donoghue et al
Serrano P, Johnson MA, Chatterjee A, Neuman BW, Joseph JS, Buchmeier MJ,
Kuhn P, W€uthrich K (2009) Nuclear magnetic resonance structure of the
nucleic acid-binding domain of severe acute respiratory syndrome
coronavirus nonstructural protein 3. J Virol 83: 12998 – 13008
Shi C-S, Qi H-Y, Boularan C, Huang N-N, Abu-Asab M, Shelhamer JH, Kehrl JH
(2014) SARS-coronavirus open reading frame-9b suppresses innate
immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6
signalosome. J Immunol 193: 3080 – 3089
Shi M, Wang L, Fontana P, Vora S, Zhang Y, Fu T-M, Lieberman J, Wu H
(2020) SARS-CoV-2 Nsp1 suppresses host but not viral translation through
a bipartite mechanism. bioRxiv https://doi.org/10.1101/2020.09.18.302901
[PREPRINT]
Sillitoe I, Bordin N, Dawson N, Waman VP, Ashford P, Scholes HM, Pang CSM,
Woodridge L, Rauer C, Sen N et al (2021) CATH: increased structural
coverage of functional space. Nucleic Acids Res 49: D266 –D273
Sillitoe I, Cuff AL, Dessailly BH, Dawson NL, Furnham N, Lee D, Lees JG, Lewis
TE, Studer RA, Rentzsch R et al (2012) New functional families (FunFams)
in CATH to improve the mapping of conserved functional sites to 3D
structures. Nucleic Acids Res 41: D490 –D498
Smietanski M, Werner M, Purta E, Kaminska KH, Stepinski J, Darzynkiewicz E,
Nowotny M, Bujnicki JM (2014) Structural analysis of human 20-O-ribose
methyltransferases involved in mRNA cap structure formation. Nat
Commun 5: 3004
Smith GR, Sternberg MJE (2002) Prediction of protein–protein interactions by
docking methods. Curr Opin Struct Biol 12: 28 – 35
Srinivasan S, Cui H, Gao Z, Liu M, Lu S, Mkandawire W, Narykov O, Sun M,
Korkin D (2020) Structural genomics of SARS-CoV-2 indicates evolutionary
conserved functional regions of viral proteins. Viruses 12: 360
Steinegger M, Meier M, Mirdita M, Vöhringer H, Haunsberger SJ, Söding J
(2019) HH-suite3 for fast remote homology detection and deep protein
annotation. BMC Bioinformatics 20: 473
Su D, Lou Z, Sun F, Zhai Y, Yang H, Zhang R, Joachimiak A, Zhang XC,
Bartlam M, Rao Z (2006) Dodecamer structure of severe acute respiratory
syndrome coronavirus nonstructural protein nsp10. J Virol 80: 7902 – 7908
Subissi L, Imbert I, Ferron F, Collet A, Coutard B, Decroly E, Canard B (2014)
SARS-CoV ORF1b-encoded nonstructural proteins 12–16: replicative
enzymes as antiviral targets. Antiviral Res 101: 122 – 130
Surjit M, Kumar R, Mishra RN, Reddy MK, Chow VTK, Lal SK (2005) The Severe
acute respiratory syndrome coronavirus nucleocapsid protein is
phosphorylated and localizes in the cytoplasm by 14-3-3-mediated
translocation. J Virol 79: 11476 – 11486
Surya W, Li Y, Torres J (2018) Structural model of the SARS coronavirus E
channel in LMPG micelles. Biochim Biophys Acta 1860: 1309 – 1317
Szeto C, Chatzileontiadou DSM, Nguyen AT, Sloane H, Lobos CA, Jayasinghe D,
Halim H, Smith C, Riboldi-Tunnicliffe A, Grant EJ et al (2021) The
presentation of SARS-CoV-2 peptides by the common HLA-A∗02:01
molecule. iScience 24: 102096
Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L (2020)
Characterization of the receptor-binding domain (RBD) of 2019 novel
coronavirus: implication for development of RBD protein as a viral
attachment inhibitor and vaccine. Cell Mol Immunol 17: 613 – 620
Tayeb-Fligelman E, Cheng X, Tai C, Bowler JT, Griner S, Sawaya MR, Seidler
PM, Jiang YX, Lu J, Rosenberg GM et al (2021) Inhibition of amyloid
formation of the nucleoprotein of SARS-CoV-2. bioRxiv https://doi.org/10.
1101/2021.03.05.434000 [PREPRINT]
Taylor JK, Coleman CM, Postel S, Sisk JM, Bernbaum JG, Venkataraman T,
Sundberg EJ, Frieman MB (2015) Severe acute respiratory syndrome
coronavirus ORF7a inhibits bone marrow stromal antigen 2 virion
tethering through a novel mechanism of glycosylation interference. J Virol
89: 11820 – 11833
Teoh K-T, Siu Y-L, Chan W-L, Schl€uter MA, Liu C-J, Peiris JSM, Bruzzone R,
Margolis B, Nal B (2010) The SARS coronavirus E protein interacts with
PALS1 and alters tight junction formation and epithelial morphogenesis.
Mol Biol Cell 21: 3838 – 3852
The UniProt Consortium (2019) UniProt: a worldwide hub of protein
knowledge. Nucleic Acids Res 47: D506 –D515
Thoms M, Buschauer R, Ameismeier M, Koepke L, Denk T, Hirschenberger M,
Kratzat H, Hayn M, Mackens-Kiani T, Cheng J et al (2020) Structural basis
for translational shutdown and immune evasion by the Nsp1 protein of
SARS-CoV-2. Science 369: 1249 – 1255
Umate P, Tuteja N, Tuteja R (2011) Genome-wide comprehensive analysis of
human helicases. Commun Integr Biol 4: 118 – 137
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel
AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H (2020)
Endothelial cell infection and endotheliitis in COVID-19. Lancet 395:
1417 – 1418
te Velthuis AJW, van den Worm SHE, Snijder EJ (2012) The SARS-coronavirus
nsp7+nsp8 complex is a unique multimeric RNA polymerase capable of
both de novo initiation and primer extension. Nucleic Acids Res 40:
1737 – 1747
Vennema H, Godeke GJ, Rossen JW, Voorhout WF, Horzinek MC, Opstelten DJ,
Rottier PJ (1996) Nucleocapsid-independent assembly of coronavirus-like
particles by co-expression of viral envelope protein genes. EMBO J 15:
2020 – 2028
Wada M, Lokugamage KG, Nakagawa K, Narayanan K, Makino S (2018)
Interplay between coronavirus, a cytoplasmic RNA virus, and nonsense-
mediated mRNA decay pathway. Proc Natl Acad Sci USA 115:
E10157 – E10166
Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler D (2020)
Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein.
Cell 181: 281 – 292.e6
Waman VP, Sen N, Varadi M, Daina A, Wodak SJ, Zoete V, Velankar S, Orengo
C (2021) The impact of structural bioinformatics tools and resources on
SARS-CoV-2 research and therapeutic strategies. Brief Bioinform 22:
742 – 768
Wang B, Thurmond S, Zhou K, Sanchez-Aparicio MT, Fang J, Lu J, Gao L, Ren
W, Cui Y, Veit EC et al (2020) Structural basis for STAT2 suppression by
flavivirus NS5. Nat Struct Mol Biol 27: 875 – 885
Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, Heer
FT, de Beer TA P, Rempfer C, Bordoli L et al (2018) SWISS-MODEL:
homology modelling of protein structures and complexes. Nucleic Acids
Res 46: W296 –W303
Xia S, Yan L, Xu W, Agrawal AS, Algaissi A, Tseng C-T, Wang Q, Du L,
Tan W, Wilson IA et al (2019) A pan-coronavirus fusion inhibitor
targeting the HR1 domain of human coronavirus spike. Sci Adv 5:
eaav4580
Xu X, Lou Z, Ma Y, Chen X, Yang Z, Tong X, Zhao Qi, Xu Y, Deng H, Bartlam M
et al (2009) Crystal structure of the C-terminal cytoplasmic domain of
non-structural protein 4 from mouse hepatitis virus A59. PLoS One 4:
e6217
Yachdav G, Kloppmann E, Kajan L, Hecht M, Goldberg T, Hamp T,
Hönigschmid P, Schafferhans A, Roos M, Bernhofer M et al (2014)
PredictProtein—an open resource for online prediction of protein
structural and functional features. Nucleic Acids Res 42: W337 –W343
Yan L, Ge J, Zheng L, Zhang Y, Gao Y, Wang T, Huang Y, Yang Y, Gao S, Li M
et al (2021a) Cryo-EM structure of an extended SARS-CoV-2 replication
ª 2021 The Authors Molecular Systems Biology 17: e10079 | 2021 23 of 24
Sean I O’Donoghue et al Molecular Systems Biology
and transcription complex reveals an intermediate state in cap synthesis.
Cell 184: 184 – 193.e10
Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q (2020) Structural basis for the
recognition of SARS-CoV-2 by full-length human ACE2. Science 367:
1444 – 1448
Yan R, Zhang Y, Li Y, Ye F, Guo Y, Xia L, Zhong X, Chi X, Zhou Q (2021b)
Structural basis for the different states of the spike protein of SARS-CoV-2
in complex with ACE2. Cell Res 31: 717 – 719
Yin W, Mao C, Luan X, Shen D-D, Shen Q, Su H, Wang X, Zhou F, Zhao W,
Gao M et al (2020) Structural basis for inhibition of the RNA-dependent
RNA polymerase from SARS-CoV-2 by remdesivir. Science 368: 1499 – 1504
Yu H-H, Chu K-H, Yang Y-H, Lee J-H, Wang L-C, Lin Y-T, Chiang B-L (2011)
Genetics and Immunopathogenesis of IgA Nephropathy. Clin Rev Allergy
Immunol 41: 198 – 213
Yuan M, Wu NC, Zhu X, Lee C-CD, So RTY, Lv H, Mok CKP, Wilson IA (2020a)
A highly conserved cryptic epitope in the receptor binding domains of
SARS-CoV-2 and SARS-CoV. Science 368: 630 – 633
Yuan S, Peng L, Park JJ, Hu Y, Devarkar SC, Dong MB, Shen Q, Wu S, Chen S,
Lomakin IB et al (2020b) Nonstructural protein 1 of SARS-CoV-2 is a
potent pathogenicity factor redirecting host protein synthesis machinery
toward viral RNA. Mol Cell 80: 1055 – 1066.e6
Zhang X, Zhan X, Yan C, Zhang W, Liu D, Lei J, Shi Y (2019) Structures of the
human spliceosomes before and after release of the ligated exon. Cell Res
29: 274 – 285
Zheng W, Zhang C, Li Y, Pearce R, Bell EW, Zhang Y (2021) Folding non-
homologous proteins by coupling deep-learning contact maps with I-
TASSER assembly simulations. Cell Rep Methods 1: 100014
Zhou Z, Huang C, Zhou Z, Huang Z, Su L, Kang S, Chen X, Chen Q, He S, Rong
X et al (2021) Structural insight reveals SARS-CoV-2 ORF7a as an
immunomodulating factor for human CD14+ monocytes. iScience 24:
102187
Zinzula L, Basquin J, Bohn S, Beck F, Klumpe S, Pfeifer G, Nagy I, Bracher A,
Hartl FU, Baumeister W (2021) High-resolution structure and biophysical
characterization of the nucleocapsid phosphoprotein dimerization domain
from the Covid-19 severe acute respiratory syndrome coronavirus 2.
Biochem Biophys Res Commun 538: 54 – 62
License: This is an open access article under the
terms of the Creative Commons Attribution License,
which permits use, distribution and reproduction in
any medium, provided the original work is properly
cited.
24 of 24 Molecular Systems Biology 17: e10079 | 2021 ª 2021 The Authors
Molecular Systems Biology Sean I O’Donoghue et al
